WO2021199933A1 - Medical instrument and medical instrument set - Google Patents

Medical instrument and medical instrument set Download PDF

Info

Publication number
WO2021199933A1
WO2021199933A1 PCT/JP2021/008959 JP2021008959W WO2021199933A1 WO 2021199933 A1 WO2021199933 A1 WO 2021199933A1 JP 2021008959 W JP2021008959 W JP 2021008959W WO 2021199933 A1 WO2021199933 A1 WO 2021199933A1
Authority
WO
WIPO (PCT)
Prior art keywords
medical device
main body
pancreatic
hole
traction
Prior art date
Application number
PCT/JP2021/008959
Other languages
French (fr)
Japanese (ja)
Inventor
直希 荒巻
美穂 甲斐
昭宏 高橋
智哉 小松
由紀子 田邊
浩一 早川
Original Assignee
テルモ株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by テルモ株式会社 filed Critical テルモ株式会社
Priority to JP2022511715A priority Critical patent/JPWO2021199933A1/ja
Priority to CN202180008266.9A priority patent/CN114929299A/en
Publication of WO2021199933A1 publication Critical patent/WO2021199933A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/11Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M27/00Drainage appliance for wounds or the like, i.e. wound drains, implanted drains

Definitions

  • the present invention relates to a medical device and a medical device set.
  • pancreaticoduodenectomy in which the pancreatic head and its surrounding tissues are resected, is known as one of the treatment methods for tumors near the pancreatic head. After pancreaticoduodenectomy, a procedure is performed to join the pancreatic parenchyma and the jejunum.
  • pancreatic parenchyma and the jejunum are sutured by a suture member such as a biodegradable suture.
  • a pancreatic duct tube (see, for example, Patent Document 1 below) is used to prevent pancreatic juice discharged from the pancreatic duct from leaking to the junction where the pancreatic parenchyma and the jejunum are joined. May be done.
  • the pancreatic duct tube is placed in a living body in a state where one end of the pancreatic duct tube is inserted into the pancreatic duct and the other end of the pancreatic duct tube is led out to the outside of the body via the inside of the jejunum or the like.
  • the indwelling pancreatic duct tube suppresses leakage to the joint by draining pancreatic juice discharged from the pancreatic duct to the outside of the body.
  • the present inventors are diligently studying a medical device that can easily join a pair of gastrointestinal tracts such as the jejunum and the pancreatic parenchyma.
  • an object of the present invention is to provide a medical device capable of easily joining a pair of digestive tracts.
  • the medical device according to the present invention that achieves the above object is arranged between a pair of gastrointestinal tracts to be joined, and is configured so that the tubular member having a lumen and the tubular member can be fixed to at least one gastrointestinal tract. It has a fixing portion for generating a fixing force for the purpose, and the fixing portion is configured so that its outer shape can be expanded by an external force.
  • the medical device and the medical device set according to the present invention are configured as described above, a pair of digestive tracts can be easily joined.
  • FIG. 5 is an enlarged cross-sectional view taken along line 5-5 of FIG. It is the schematic for showing the modification of the hole part which constitutes a fixed part. It is sectional drawing for showing the expanded state of the fixed part of the medical device which concerns on FIG. It is the schematic for showing the modification of the hole part which constitutes a fixed part.
  • FIG. 5 is a cross-sectional view for showing an expanded state of a fixed portion of the medical device according to FIG. It is the schematic for showing the modification of the hole part which constitutes a fixed part. It is a side view for showing the expanded state of the fixed part of the medical device which concerns on FIG. It is a schematic diagram for showing the modification 1 of the medical device which concerns on FIG. It is a side view for showing the expanded state of the fixed part of the medical device which concerns on FIG. It is a schematic diagram for showing the modification 2 of the medical device which concerns on FIG. It is the schematic for showing the expanded state of the fixed part of the medical device which concerns on FIG.
  • FIG. 6 is a schematic cross-sectional view for explaining pancreatic parenchymal-jejunal anastomosis.
  • FIG. 6 is a schematic cross-sectional view for explaining pancreatic parenchymal-jejunal anastomosis.
  • FIG. 6 is a schematic cross-sectional view for explaining pancreatic parenchymal-jejunal anastomosis. It is a schematic perspective view for explaining a pancreatic parenchymal-jejunal anastomosis. It is a schematic perspective view for explaining a pancreatic parenchymal-jejunal anastomosis.
  • FIG. 6 is a schematic cross-sectional view for explaining pancreatic parenchymal-jejunal anastomosis. It is a figure which shows the medical device set when the fixed part is formed at both ends of the medical device.
  • FIG. 2 is a schematic cross-sectional view for explaining pancreatic parenchymal-jejunal anastomosis using the medical device set shown in FIG. 27.
  • FIG. 1 is a diagram provided for explaining a medical device set 1 according to an embodiment of the present invention.
  • the medical device set 1 can be applied to a procedure for joining predetermined biological organs (for example, gastrointestinal anastomosis).
  • a pancreatic parenchymal-jejunal anastomosis technique for joining the pancreatic parenchyma B1 and the jejunum B2 will be described as an example of a procedure using the medical device set 1.
  • the medical device set 1 has a fusion promoting sheet 100 and a medical device 200.
  • FIG. 2 is an enlarged cross-sectional view showing a through hole 112 of the fusion promoting sheet 100 constituting the medical device set 1.
  • the fusion promoting sheet 100 is formed of a biodegradable sheet having a plurality of through holes 112 and has a main body portion 110 that promotes fusion of living tissues.
  • the main body 110 is composed of a sheet-shaped member.
  • each through hole 112 formed in the main body 110 is regularly and periodically provided in the plane direction of the main body 110.
  • each through hole 112 may be randomly provided in each portion in the surface direction of the main body portion 110.
  • each through hole 112 extends substantially vertically between the front surface 111 and the back surface 113 along the thickness direction of the main body 110 (vertical direction in FIG. 2).
  • Each through hole 112 may be bent or curved in a zigzag shape between the front surface 111 and the back surface 113 in a cross section along the thickness direction of the main body 110.
  • Each through hole 112 has a substantially circular planar shape (the shape when the front surface 111 of the main body 110 or the back surface 113 of the main body 110 is viewed in a plan view).
  • the planar shape of each through hole 112 is not particularly limited, and may be, for example, an ellipse or a polygon (rectangle, triangle, etc.). Further, the plane shape and the cross-sectional shape may be different for each through hole 112.
  • the main body 110 has a substantially circular planar shape.
  • the planar shape of the main body 110 is not particularly limited, and may be, for example, an ellipse or a polygon (rectangle, triangle, etc.). Further, the plane shape and the cross-sectional shape may be different for each through hole 112.
  • the thickness of the main body 110 is not particularly limited, but is preferably 0.05 mm to 0.3 mm, more preferably 0.1 to 0.2 mm.
  • the strength is such that the main body 110 is not damaged when the fusion promoting sheet 100 is handled.
  • the thickness of the main body 110 is 0.3 mm or less (particularly 0.2 mm or less)
  • the main body 110 adheres to the biological tissue to which the main body 110 is applied and follows the biological tissue. It can be provided with sufficient flexibility.
  • the main body 110 has a value of the ratio of the hole diameter D of the through hole 112 to the pitch P of the through hole 112 (distance between adjacent through holes 112 as shown in FIG. 2) of 0.25 or more and less than 40. Is preferable.
  • the hole diameter D of the through hole 112 is equal to the diameter of the perfect circle.
  • the diameter of a perfect circle (circle) having the same area as the area of the opening of the through hole 112 (the portion of the through hole 112 facing the front surface 111 or the back surface 113).
  • the equivalent diameter can be the hole diameter D of the through hole 112.
  • the main body 110 has a plurality of through holes 112, there are a plurality of values of the hole diameter D corresponding to each through hole 112. Therefore, in the present embodiment, in calculating the above-mentioned ratio value, the arithmetic mean value of two or more points of the hole diameter D values corresponding to the plurality of through holes 112 is used as the representative value of the hole diameter D. ..
  • the pitch P of the plurality of through holes 112 is defined by the shortest distance between the openings of the two through holes 112. However, as for the value of the pitch P, there are a plurality of values of the pitch P corresponding to the combination of the adjacent through holes 112. Therefore, in the present embodiment, in calculating the above-mentioned ratio value, the arithmetic mean value of two or more points of the pitch P values corresponding to the combinations of the adjacent through holes 112 is used as the representative value of the pitch P. And.
  • the pitch P, the hole diameter D, the ratio of the hole diameter D to the pitch P, and the like of the through hole 112 are examples, and are not limited thereto.
  • the main body 110 can be made of a biodegradable material.
  • the constituent material of the main body 110 is not particularly limited, and examples thereof include biodegradable resins.
  • biodegradable resin for example, those described in Japanese Patent Publication No. 2011-528275, Japanese Patent Publication No. 2008-514719, International Publication No. 2008-1952, Japanese Patent Publication No. 2004-509205 and the like are known.
  • Biodegradable (co) polymers can be used. Specifically, it is selected from the group consisting of (1) aliphatic polyester, polyester, polyacid anhydride, polyorthoester, polycarbonate, polyphosphazene, polyphosphate ester, polyvinyl alcohol, polypeptide, polysaccharide, protein, and cellulose.
  • the biodegradable sheet is selected from the group consisting of aliphatic polyesters, polyesters, polyacid anhydrides, polyorthoesters, polycarbonates, polyphosphazenes, polyphosphates, polyvinyl alcohols, polypeptides, polysaccharides, proteins, and celluloses. It preferably contains at least one biodegradable resin selected from the group consisting of a polymer and a copolymer composed of one or more monomers constituting the polymer.
  • the manufacturing method of the main body 110 is not particularly limited, and examples thereof include a method of manufacturing a fiber made of the above-mentioned biodegradable resin and manufacturing a mesh-shaped sheet using the fiber.
  • the method for producing the fiber made of a biodegradable resin is not particularly limited, and examples thereof include an electrospinning method (electrospinning method / electrostatic spinning method) and a melt blow method.
  • an electrospinning method electrospinning method / electrostatic spinning method
  • melt blow method melt blow method.
  • the main body 110 only one type may be selected and used from the above methods, or two or more types may be selected and appropriately combined.
  • the biodegradable sheet according to the present invention is obtained by spinning the fibers made of the biodegradable resin described above according to a conventional method and knitting the obtained fibers into a mesh shape. Members may be manufactured.
  • the main body 110 induces a biological reaction by the constituent material of the biodegradable resin constituting the main body 110.
  • the main body 110 induces the expression of biological components such as fibrin by this action.
  • the biological components induced in this way can promote fusion by accumulating so as to penetrate through the through hole 112 of the main body 110. Therefore, by arranging the main body 110 between the pancreatic parenchyma B1 and the jejunum B2, promotion of fusion by the above mechanism can occur.
  • the material of the fusion promoting sheet 100 does not have to be biodegradable as long as it can promote the fusion of biological organs. Further, the fusion promoting sheet 100 may not have a through hole 112 formed regardless of the material, as long as it can promote the fusion of living organs.
  • the medical device 200 is used to maintain a state in which the lumens of the pair of gastrointestinal tracts to be joined are in communication, such as the pancreatic parenchyma B1 and the jejunum B2.
  • 3 to 12 are diagrams for explaining the medical device 200.
  • the one end side of the medical device 200 that can be inserted into the jejunum B2 is referred to as the "base end side”
  • the other end side of the medical device 200 that can be inserted into the pancreatic parenchyma B1 is referred to as the "tip side”.
  • the direction from the tip end side to the base end side (or the opposite direction) is referred to as an axial direction X.
  • the medical device 200 is attached to the main body 210 (corresponding to a “tubular member”) arranged between the digestive tracts (pancreatic parenchyma B1 and jejunum B2) to be joined, and at least one gastrointestinal tract (pancreatic parenchyma B1).
  • the fixing portion 220 that generates a fixing force for forming the main body portion 210 so that it can be fixed
  • the operating portion 230 that deforms the fixing portion 220 by transmitting an external force to the fixing portion 220
  • the operating portion 230 that the operating portion 230 fixes the fixing portion 220 It has an auxiliary unit 240 that maintains a state in which an external force is transmitted to the pancreas.
  • the main body 210 includes a lumen L.
  • the shape of the hollow cross section is configured as a circular shape such as a perfect circle or an ellipse.
  • the outer diameter r1 and inner diameter of the main body 210 are not particularly limited, but are preferably 3 Fr (outer diameter 1.0 mm, inner diameter 0.5 mm) to 15 Fr (outer diameter 5.0 mm, inner diameter 3.0 mm), and more preferably. It is 4 Fr (outer diameter 1.3 mm, inner diameter 0.7 mm) to 6 Fr (outer diameter 2.0 mm, inner diameter 1.4 mm).
  • the pancreatic juice is introduced into the lumen L from the distal opening 210A, and the pancreatic juice is drained from the proximal opening 210B to the jejunum B2.
  • the main body 210 can be made of an elastic, non-biodegradable material.
  • the main body 210 spontaneously falls off into the jejunum B2 after a predetermined period (weeks to months) has passed since the operator anastomosed the digestive tract and placed the main body 210 in the living body, and the main body 210 was in vitro. Derived to. That is, the main body 210 functions as a so-called internal fistula tube.
  • the main body 210 is provided with at least one side hole 210P on the tip side.
  • the side hole 210P is arranged between the pancreatic parenchyma B1 and the jejunum B2, the pancreatic juice is introduced into the lumen L and drained into the jejunum B2. Therefore, the side hole 210P can drain pancreatic juice into the jejunum B2 even when the distal end side opening 210A is occluded.
  • the constituent materials of the main body 210 are not particularly limited, and are, for example, vinyl chloride, polyurethane elastomer, polystyrene elastomer, styrene-ethylene-butylene-styrene copolymer (SEBS), styrene-ethylene-propylene-styrene copolymer (SEPS). It can be composed of a thermoplastic elastomer such as, nylon, a thermoplastic resin such as PET, rubber, a silicone elastomer or the like.
  • the fixing portions 220 are a plurality of holes 221 provided in a certain area on the tip end side of the main body 210, and a plurality of fixed portions 220 arranged between the holes 221 respectively. It is composed of a beam portion 222 of the above.
  • each of the beam portions 222 is bent outward in the radial direction (diameter direction), whereby the outer diameter (outer diameter) of the medical instrument 200 is obtained.
  • r1 can be expanded into a circular shape (radial) (see FIG. 5).
  • each of the holes 221 is bent outward in the radial direction (diameter direction) to expose the exposed surface 221 m.
  • the fixing portion 220 can expand the inner wall of the pancreatic duct B1b to increase the fitting force (resistance force) of the medical device 200 with respect to the pancreatic parenchyma B1. Therefore, the fixing portion 220 can fix the main body portion 210 to the pancreatic duct B1b.
  • the surgeon inserts the medical device 200 into the pancreatic duct B1b once, fixes the main body 210 to the pancreatic duct B1b by the fixing portion 220, and the medical device 200 is inserted into the cavity of the pancreatic parenchyma B1 (pancreatic duct B1b).
  • the state can be maintained.
  • the surgeon moves the circumference of the cut surface B1a of the pancreatic parenchyma B1 (anterior wall B1d and posterior wall B1c) and the jejunum B2 without inserting and removing the medical device 200 from the pancreatic duct B1b, and moves the pancreatic parenchyma B1 and the jejunum. B2 can be joined.
  • the operator can perform anastomosis between the pancreatic parenchyma B1 and the jejunum B2 without suturing the pancreatic duct B1b and the jejunum B2, and can easily join the pancreatic parenchyma B1 and the jejunum B2.
  • the hole portion 221 and the beam portion 222 are each provided at eight locations. Further, each of the hole portions 221 (and each of the beam portions 222) is provided at a predetermined interval with respect to the circumferential direction ⁇ of the fixed portion 220.
  • the number of holes 221 and beam 222 is not particularly limited, and preferably 2 to 16 holes, more preferably 4 to 8 holes, respectively.
  • the hole portion 221 is a linear cut (slit) formed in the main body portion 210.
  • Each length k of the hole 221 along the longitudinal direction is the same or substantially the same as shown in FIG. 3, preferably 3 to 8 mm.
  • the method for producing the hole 221 is not particularly limited, but the hole 221 can be produced, for example, by laser processing.
  • the hole portion 221 is formed so as to intersect in the axial direction X.
  • the inclination angle ⁇ 1 of the hole portion 221 with respect to the axial direction X is preferably 0 to 89 °, more preferably 17 to 45 °. Is.
  • the outer diameter r2 (see FIG. 4) of the fixed portion 220 after expansion is preferably 2 to 4 times the inner diameter of the pancreatic duct B1b.
  • the outer diameter r2 of the fixed portion 220 after expansion is preferably 4 to 8 mm, more preferably 5 mm.
  • the surgeon changes the outer diameter r2 after the diameter of the fixing portion 220 is expanded so that the main body 210 can be fixed to the digestive tract. (Hereinafter referred to as the fixing force of the medical device 200) can be adjusted.
  • the fixing force of the medical device 200 after expansion is preferably 1.1 to 4 times that before expansion.
  • the fixing force is constant after inserting the medical device 200 into the pancreatic parenchyma B1 and expanding the outer diameter r1 of the medical device 200 by the fixing portion 220, and then grasping the proximal end side of the medical device 200 with forceps or the like. Maximum strength when pulled at speed.
  • the fixing force before expansion is 1.2 to 1.7N
  • the fixing force after expansion is preferably 2 to 5N.
  • the shape of the hole portion 221 is not particularly limited.
  • the hole 221 may have a curved shape (see FIG. 6) such as an elliptical arc.
  • a curved shape see FIG. 6
  • the shape of the hole 221 curved like an elliptical arc, it is possible to adjust the shape of the beam portion 222 as seen from the axial direction X when the fixed portion 220 is compressed in the axial direction X by an external force. Yes (see FIGS. 5 and 7). Therefore, the operator can adjust the contact amount (contact point) between the inner wall of the pancreatic duct B1b and the beam portion 222, and adjust the fixing force of the medical device 200 to the digestive tract.
  • the hole portion 221 may have a polygonal line shape (see FIG. 8) formed by combining a plurality of straight lines.
  • the angle (inclination angle ⁇ 2) of the hole portion 221 with respect to the virtual line m1 on the start point 221a side is preferably larger than the angle (inclination angle ⁇ 3) of the end point 221b side of the hole portion 221 with respect to the virtual line m1.
  • the fixing portion 220 can be expected to generate more fixing force of the medical device 200 to the digestive tract.
  • hole 221 may be spiral.
  • the direction in which the hole 221 extends is not particularly limited.
  • each of the start point 221a (or end point 221b) of the hole portion 221 is arranged so as to be aligned with the circumferential direction ⁇ of the main body portion 210 (at the same position with respect to the axial direction X of the main body portion 210).
  • they may be arranged in a zigzag shape (positions different from each other with respect to the axial direction X of the main body 210).
  • the fixing portion 220 is compressed in the axial direction X by an external force.
  • the outer shape of the medical device 200 can be expanded into a substantially rectangular shape.
  • one or more hole portions 223 having a length shorter than that of the hole portion 221 may be formed on the base end side of the beam portion 222.
  • the base end side of the beam portion 222 is more flexible than the tip end side where the hole portion 223 is not formed due to the formation of the hole portion 223. Therefore, when the beam portion 222 is compressed in the axial direction X by an external force, the beam portion 222 is at a position where the hole portion 221 is formed (the starting point 221a of the hole portion 221 with respect to the axial direction X) when viewed from a direction orthogonal to the axial direction X.
  • the fixing portion 220 can be expected to generate more fixing force of the medical device 200 to the digestive tract.
  • the operation unit 230 is a connection that enables the connection between the towing unit 250 that applies an external force to the fixing unit 220 by being towed and the towing unit 250 to the main body unit 210. It has a part 260 and.
  • the auxiliary portion 240 has a hole portion 270 (“insertion hole”) that exposes the traction portion 250 that is at least partially inserted into the lumen L of the main body portion 210 starting from the connection portion 260.
  • a locking portion 280 configured so that at least a part of the traction portion 250 can be locked to the hole portion 270.
  • the traction portion 250 has a predetermined length and has a long-shaped member having a cross-sectional shape that can be inserted into the lumen L of the main body portion 210 and the hole portion 270 (for example, a small-diameter string-shaped member or a predetermined width). It can be composed of a band-shaped member having the above. There is no particular limitation on the length of the towed portion 250 and the like.
  • connection portion 260 is formed at the tip of the main body portion 210.
  • the method of fixing the base end of the traction portion 250 to the tip end side of the main body portion 210 is not particularly limited, but it can be fixed by suture or adhesive, connected by fusion or the like, or one end of the traction portion 250 has a ring shape. It can be tied to and hooked on the tip of the main body 210.
  • the hole 270 is formed in the main body 210 and is arranged on the base end side (center side from the fixed portion 220 formed on one end side of the main body 210) with respect to the fixed portion 220 formed at the tip end.
  • the traction portion 250 in the present embodiment is inserted into the lumen L of the main body portion 210 from the connection portion 260 formed at the tip of the main body portion 210 to the hole portion 270 formed on the base end side of the main body portion 210.
  • An external force can be applied to the fixed portion 220 by being pulled. Therefore, the operator can deform the fixed portion 220 without directly applying an external force to the fixed portion 220. Further, the operator can adjust the position of pulling the towing portion 250 according to the procedure by providing the hole portion 270 on the side surface of the main body portion 210.
  • An external force can be applied to compress the fixing portion 220 in the axial direction X.
  • the locking portion 280 is one or more protrusions provided in a certain range of the traction portion 250.
  • Each of the locking portions 280 is made of an elastic material, and when a tension of a predetermined value or more is applied to the traction portion 250, the locking portion 280 elastically deforms to pass through (overcome) the hole portion 270 or to the hole portion 270. It can be locked.
  • the shape (cross-sectional shape) of the protrusion is not particularly limited, and may be, for example, a spine shape (a state in which a sharp shape is formed by a straight line) or a sickle shape (a sharp shape is partially curved). It may be in a spherical shape (a state formed by tying a traction portion 250).
  • the operator is pulling the towing portion 250 by locking any of the locking portions 280 provided in the towing portion 250 to the hole portion 270 when the towing portion 250 is towed (hereinafter, referred to as a state). It can maintain a traction state). Therefore, the operator is in a state in which the fixed portion expands the outer shape by the locking portion 280 even when the traction portion 250 is not towed (while the operating portion 230 is not being operated) (hereinafter referred to as an expanded state). Can be maintained.
  • the material of the traction portion 250 is not particularly limited as long as the fixing portion 220 can be compressed in the axial direction X when the traction portion 250 is towed while being inserted through the lumen L.
  • the strength of the traction portion 250 decreases when the traction portion 250 is decomposed in a living body. Then, the traction force of the traction portion 250 with respect to the main body portion 210 is reduced (the traction state is released).
  • the fixed portion 220 is changed from an expanded state (a state in which each of the beam portions 222 is bent outward in the radial direction) to a natural state (a state in which each of the beam portions 222 is not bent) due to the elastic force of the main body portion 210. Return to. Therefore, the fixing force of the medical device 200 to the pancreatic parenchyma B1 is weakened, and the medical device 200 can naturally fall into the jejunum B2.
  • the constituent material of the traction portion 250 is not particularly limited, and for example, vinyl chloride, polyurethane elastomer, polystyrene elastomer, styrene-ethylene-butylene-styrene copolymer (SEBS), styrene-ethylene-propylene-styrene copolymer (Styrene-ethylene-propylene-styrene copolymer). It can be composed of a thermoplastic elastomer such as SEPS), a thermoplastic resin such as nylon or PET, or a rubber or silicone elastomer.
  • cross-sectional shape and thinness of the traction portion 250 are not particularly limited as long as they do not interfere with the anastomosis of the digestive tract.
  • the traction portion 250 may have a needle portion having biocompatibility at the other end portion opposite to the one end portion fixed to the connection portion 260. Thereby, the operator can suture and fix the jejunum B2 on the serosa of the jejunum B2 at the traction portion 250 to bring the jejunum B2 and the pancreatic parenchyma B1 close to each other.
  • the locking portion 280 may be provided on the hole portion 270 side.
  • the hole 270 may be provided with, for example, a valve body or a notch.
  • the locking portion 280 can maintain the traction state by sandwiching at least a part of the traction portion 250.
  • the locking portion 280 is a valve body provided on the hole portion 270 side, the traction portion 250 is elastically deformed when the operator applies a tension equal to or higher than a predetermined value to the traction portion 250. It can be configured to be able to move forward and backward.
  • the locking portion 280 is a notch (slit) provided on the hole portion 270 side, the locking portion 280 is removed from the notch when the operator applies a tension equal to or higher than a predetermined value to the traction portion 250.
  • the traction unit 250 can be configured to be able to move forward and backward.
  • the material of the locking portion 280 is not particularly limited as long as it has elasticity, but it is preferably composed of a biodegradable material.
  • the locking portion 280 is decomposed in the living body, the traction state is released. Therefore, the fixing force of the medical device 200 to the pancreatic parenchyma B1 is weakened, and the medical device 200 can naturally fall into the jejunum B2.
  • the locking portion 280 is made of a biodegradable material
  • the traction portion 250 may be made of a non-biodegradable material.
  • the constituent material of the locking portion 280 is not particularly limited, and for example, vinyl chloride, polyurethane elastomer, polystyrene elastomer, styrene-ethylene-butylene-styrene copolymer (SEBS), styrene-ethylene-propylene-styrene copolymer (SEPS). ) And the like, a thermoplastic resin such as nylon and PET, rubber, a silicone elastomer and the like.
  • the shape of the locking portion 280 is not particularly limited as long as it can pass through the hole 270 of the main body 210 or be locked in the hole 270 by elastic deformation. Further, the shapes of the locking portions 280 may be the same as or different from each other.
  • the medical device 200 has been described as having the main body 210, the fixing 220, the operating 230, and the auxiliary 240, but the main body 210 and the fixing 220 It may be configured by the operation unit 230. Further, the tow portion 250 does not have to be integrally formed with the main body portion 210. In this case, the surgeon prepares the traction portion 250 separately from the medical device 200 during the procedure. The surgeon can use the medical device 200 and the traction portion 250 in an appropriate combination according to the progress of the procedure and the like.
  • the medical device 200 is arranged between the pancreatic parenchyma B1 and the jejunum B2 (a pair of gastrointestinal tracts to be joined), and has a main body 210 (tubular member) having a lumen L and a main body portion 210 (tubular member). It has a fixing portion 220 that generates a fixing force for forming the main body portion 210 so as to be able to be fixed to the pancreatic parenchyma B1 (at least one gastrointestinal tract), and the fixing portion 220 has an outer shape (outer diameter r1) by an external force. ) Is extensible.
  • the fixing portion 220 expands the inner wall of the pancreatic duct B1b by expanding the outer shape (outer diameter r1) of the medical device 200, and the fitting force (resistance) of the medical device 200 to the pancreatic parenchyma B1. Power) can be increased. Therefore, the fixing portion 220 can fix the main body portion 210 to the pancreatic duct B1b. Therefore, when the operator inserts the medical device 200 into the pancreatic duct B1b once and fixes the main body 210 to the pancreatic duct B1b by the fixing portion 220, the medical device 200 is inserted into the cavity of the pancreatic parenchyma B1 (pancreatic duct B1b). Can be maintained.
  • the surgeon moves the circumference of the cut surface B1a of the pancreatic parenchyma B1 (anterior wall B1d and posterior wall B1c) and the jejunum B2 without inserting and removing the medical device 200 from the pancreatic duct B1b, and moves the pancreatic parenchyma B1 and the jejunum. B2 can be joined. Therefore, the operator can perform anastomosis between the pancreatic parenchyma B1 and the jejunum B2 without suturing the pancreatic duct B1b and the jejunum B2, and can easily join the pancreatic parenchyma B1 and the jejunum B2.
  • the medical device 200 includes an operation unit 230 that deforms the fixed portion 220 by transmitting an external force to the fixed portion 220. Therefore, the operator can easily join the pancreatic parenchyma B1 and the jejunum B2.
  • the operation unit 230 is a connection that enables the connection between the traction unit 250 that applies an external force to the fixing unit 220 by being pulled and compresses the fixing unit 220 in the axial direction X and the traction unit 250 to the main body unit 210.
  • a unit 260 is provided. Therefore, the operator can deform the fixed portion 220 without directly applying an external force to the fixed portion 220.
  • the medical device 200 further includes an auxiliary unit 240 that maintains a state in which the operating unit 230 transmits an external force to the fixed unit 220. Therefore, the operator can maintain the expanded state of the medical device 200 even when the operation unit 230 is not operated.
  • the auxiliary portion 240 is formed on the main body portion 210, and is formed on the base end side (one end side of the main body portion 210) from the fixed portion 220 formed on the tip end side (end portion in the axial direction X) of the main body portion 210.
  • a hole 270 (insertion hole) that is arranged on the central side of the fixed portion 220 and exposes the traction portion 250 to the outside when the traction portion 250 is inserted into the lumen L, and at least one of the traction portion 250 and the hole portion 270.
  • the locking portion 280 is provided in the above and is configured so that at least a part of the traction portion 250 can be locked in the hole portion 270.
  • the operator when the traction portion 250 is towed, the operator maintains the traction state by locking any of the locking portions 280 provided on the traction portion 250 to the hole 270 of the main body portion 210. be able to. Therefore, the operator can maintain the expanded state of the medical device 200 by the locking portion 280.
  • the fixing portion 220 includes a plurality of hole portions 221 provided on the tip end side (end portion in the axial direction X) of the main body portion 210, and a plurality of beam portions 222 arranged between each of the hole portions 221.
  • the fixed portion 220 expands the outer diameter r1 by bending each of the beam portions 222 outward in the radial direction.
  • the inner wall of the pancreatic duct B1b can be expanded to increase the fitting force (resistance) of the medical device 200 to the pancreatic parenchyma B1. Therefore, the fixing portion 220 can fix the main body portion 210 to the pancreatic duct B1b.
  • the medical device set 1 has the above-mentioned medical device 200 and a fusion promoting sheet 100 that promotes fusion between the pancreatic parenchyma B1 and the jejunum B2 by being arranged between the pancreatic parenchyma B1 and the jejunum B2.
  • a fusion promoting sheet 100 that promotes fusion between the pancreatic parenchyma B1 and the jejunum B2 by being arranged between the pancreatic parenchyma B1 and the jejunum B2.
  • ⁇ Modification example 1> 13 and 14 are views provided for explaining the medical device 300 according to the first modification.
  • the medical device 300 can fix the main body 210 to the gastrointestinal tract (pancreatic parenchyma B1 and jejunum B2) to be joined and to at least one gastrointestinal tract (pancreatic parenchyma B1). It has a fixing portion 320 that generates a fixing force for forming, and an operating portion 330 that deforms the fixing portion 320 by transmitting an external force to the fixing portion 320.
  • the fixing portion 320 according to the first modification is partially housed in a plurality of holes 321 provided in a certain area on the tip end side of the main body portion 210 and inside the main body portion 210. It may be composed of a plurality of wires 322 that can protrude from each of the holes 321 when compressed in the axial direction X by an external force.
  • the operation unit 330 according to the first modification is provided so as to project toward the base end side of the main body portion 210, and can be pushed toward the tip end side of the main body portion 210 on the base end side of the wire 322. It may be composed of.
  • the tip end side of the wire 322 according to the first modification is housed in a recess provided between the inner peripheral wall and the outer peripheral wall of the main body 210. Further, the base end side of the wire 322 is provided so as to project toward the base end side of the main body 210. Further, the recess communicates with the hole 321. Therefore, the wire 322 is inserted into the main body 210 so as to partially follow the hole 321.
  • the wire 322 protruding toward the base end side of the main body 210 is pushed toward the tip end side
  • the wire 322 is compressed in the axial direction X and in the radial direction as shown in FIG. (Diameter) Bend outward.
  • the bent portion of the wire 322 protrudes from the hole portion 321.
  • the operator can expand the outer shape (outer diameter) of the medical device 300 into a circular shape (radial) by applying an external force to the wire 322.
  • the surgeon changes the outer diameter of the fixed portion 320 after the diameter is expanded and the shape of the wire 322 after the wire 322 is deformed, and is a medical device for the digestive tract.
  • the fixing force of 300 can be adjusted.
  • the wire 322 is preferably an alloy having elasto-plasticity or shape memory and having biodegradability, and can be composed of, for example, Mg or an alloy containing Mg as a main component. Since the wire 322 has elasto-plasticity or shape memory, it can maintain its shape after being deformed by an external force. Therefore, the medical device 300 can maintain the expanded state. Further, since the wire 322 has biodegradability, its strength decreases when it is decomposed in a living body. Therefore, the medical device 300 is released from the expanded state after a predetermined period of time has passed since it was placed in the living body, and can be naturally dropped into the jejunum B2.
  • ⁇ Modification 2> 15 and 16 are diagrams for explaining the medical device 400 according to the second modification.
  • the medical device 400 can fix the main body 210 to the gastrointestinal tract (pancreatic parenchyma B1 and jejunum B2) to be joined and to at least one gastrointestinal tract (pancreatic parenchyma B1). It has a fixing portion 420 that generates a fixing force for construction, and an operating portion 430 that deforms the fixing portion 420 by transmitting an external force to the fixing portion 420.
  • the fixing portion 420 according to the modified example 2 is connected to the tip end side of the operation portion 430 and the main body portion 210, which will be described later, and is provided so as to spirally wind around the main body portion 210. It may be composed of a wire 421.
  • the operation unit 430 according to the second modification may be provided by a grip portion provided on the base end side of the main body portion 210 and rotatably configured in the circumferential direction ⁇ of the main body portion 210.
  • the operator When the operator operates the operation unit 430 (rotates the wire 421 in the direction opposite to the winding direction), the winding diameter of the wire 421 increases as shown in FIG. Therefore, the operator can expand the outer shape (outer diameter) of the medical device 400 by applying an external force to the wire 421.
  • the operator can change the outer diameter of the fixing unit 420 after the expansion and adjust the fixing force of the medical device 400 to the digestive tract.
  • the wire 421 can be made of the same material as the wire 322 of the first modification.
  • the cross-sectional shape of the wire 421 is not particularly limited.
  • the wire 421 may be partially provided with protrusions, and the protrusions can further increase the fitting force (resistance force) to the pancreatic parenchyma B1.
  • connection portion between the operation unit 430 and the main body 210 is not particularly limited.
  • the operation unit 430 may be partially inserted into the lumen L of the main body unit 210.
  • the method of connecting the operation unit 430 and the main body 210 is not particularly limited, and for example, the main body 210 and the operation unit 430 can be connected by providing a protrusion or the like on the lumen L of the main body 210.
  • the protrusion may be made of the same material as the main body 210, or may be made of a different material, but may be made of, for example, a biodegradable material or a water-soluble material.
  • ⁇ Modification example 3> 17 and 18 are views provided for explaining the medical device 500 according to the third modification.
  • the medical device 500 can fix the main body 510 arranged between the digestive tracts (pancreatic parenchyma B1 and jejunum B2) to be joined and the main body 510 to at least one gastrointestinal tract (pancreatic parenchyma B1). It has a fixing portion 520 that generates a fixing force for construction, and an operating portion 530 that deforms the fixing portion 520 by transmitting an external force to the fixing portion 520.
  • the main body 510 according to the third modification is preferably an alloy having elasto-plasticity or shape memory and biodegradability, and is composed of, for example, Mg or an alloy containing Mg as a main component.
  • the fixing portion 520 according to the modified example 3 is arranged between a plurality of hole portions 521 provided in a certain region on the tip end side of the main body portion 510 and each of the hole portions 521. It may be composed of a plurality of beam portions 522.
  • the operation unit 530 according to the modification 3 may be configured by using a certain area on the base end side of the main body unit 510 as a grip portion.
  • the fixing portion 520 When the operator operates the operation portion 530 (twists the base end side of the main body portion 510), the fixing portion 520 is spirally deformed and the beam portion 522 is outside the radial direction (diameter direction) as shown in FIG. Bend in the direction. In this way, the operator can expand the outer shape (outer diameter) of the medical device 500 by applying an external force to the fixed portion 520.
  • the surgeon can change the outer diameter of the fixed portion 320 after expansion and the outer diameter when viewed from the axial direction X, and the surgeon can change the outer diameter of the medical device 200 for the digestive tract.
  • the fixing force can be adjusted.
  • FIG. 19 is a flowchart showing each procedure of the treatment method using the medical device set.
  • the treatment method is to place a medical instrument between one joint site to be joined and the other joint site to be joined (S11), and to have a sheet-shaped main body that promotes fusion of biological tissues. Inserting the promotion sheet through the medical device and fixing the medical device to one of the jointed parts (S12), at least a part of the main body of the fusion promoting sheet between one of the joined parts and the other of the joined parts. Includes joining (S13) between one joined portion and the other joined portion in a state where the above is arranged.
  • the living organ to be joined by the treatment method and the jointed part in the living organ are not particularly limited and can be arbitrarily selected.
  • pancreatic parenchymal-jejunal anastomosis will be described as an example.
  • the medical device set used in each procedure described below for example, any one can be selected from the above-mentioned medical device sets, and other medical device sets can be selected. You can also.
  • a usage example of the medical device set 1 shown in FIG. 1 will be described as a typical example that can be suitably used for each procedure.
  • detailed description of known procedure procedures and known medical devices / instruments will be omitted as appropriate.
  • arranging a fusion promoting sheet (or medical device) between living organs means that the healing promoting sheet (or medical device) comes into direct or indirect contact with the living organ.
  • the fusion-promoting sheet (or medical device) is placed in a state, the fusion-promoting sheet (or medical device) is placed in a state where a spatial gap is formed between the living organs, or both.
  • Is placed for example, one biological organ is in contact with the fusion promoting sheet (or medical device), and the other biological organ is not in contact with the healing promoting sheet (or medical device). That means at least one of them.
  • peripheral does not define a strict range (region), but a predetermined range (region) as long as the purpose of treatment (bonding between biological organs) can be achieved. Means.
  • order of the procedure procedures described in each treatment method can be changed as appropriate as long as the purpose of the treatment can be achieved.
  • relatively approaching means both bringing two or more objects to be approached close to each other and bringing only one close to the other.
  • FIG. 20 is a flowchart showing the procedure of the embodiment of the treatment method (pancreatic parenchymal-jejunal anastomosis), and FIGS. 21 to 26 are diagrams used for explaining the pancreatic parenchymal-jejunal anastomosis.
  • the biological organs to be joined are the pancreatic parenchyma B1 after pancreaticoduodenectomy and the jejunum B2.
  • the periphery of the cut surface B1a of the cut pancreatic parenchyma B1 (one joined site) and an arbitrary site of the intestinal wall of the jejunum B2 (the other joined site) will be described.
  • the treatment method according to the present embodiment is to prepare a medical device set 1 having a fusion promoting sheet 100 and a medical device 200 (S101), and insert the medical device 200 into the pancreatic duct B1b.
  • FIG. 26 a plurality of needles at both ends 920a to 920e, which will be described later, are omitted.
  • the surgeon prepares a medical device set 1 having a fusion promoting sheet 100 and a medical device 200 (S101).
  • the operator inserts the medical device 200 into the pancreatic duct B1b from the distal end side of the main body 210 (the distal end side opening 210A side shown in FIG. 1).
  • the surgeon can then fix the medical device 200 to the pancreatic parenchyma B1 (S102).
  • the operator can expand the outer shape (outer diameter r1) of the fixed portion 220 by pulling the towed portion 250 and compressing the fixed portion 220 in the axial direction X (see FIG. 22). ..
  • the operator can maintain the traction force of the traction portion 250 with respect to the main body portion 210 by locking the locking portion 280 formed in the traction portion 250 to the hole portion 270 of the main body portion 210. Therefore, the operator can fix the position of the medical device 200 with respect to the pancreatic duct B1b by the fixing portion 220.
  • the operator forms a hole 120 (see FIG. 1) in the fusion promoting sheet 100 and attaches it to the medical device 200 (S103).
  • the device used by the operator when forming the hole 120 is not particularly limited. Further, the hole 120 may be formed in the fusion promoting sheet 100 in advance in a state before use. Further, the surgeon may insert the medical device 200 into the pancreatic duct B1b after inserting the medical device 200 into the hole 120 of the fusion promoting sheet 100.
  • the operator inserts the proximal end side of the main body 210 (the proximal end side opening 210B side shown in FIG. 1) into the jejunum B2 (S104).
  • a drainage route for draining pancreatic juice from the pancreatic duct B1b to the jejunum B2 is formed (see FIG. 26), and the pancreatic juice from the pancreatic duct B1b is suppressed from leaking to the junction between the pancreatic parenchyma B1 and the jejunum B2. Can be done.
  • the operator places the fusion promoting sheet 100 on the cut surface B1a of the pancreatic parenchyma B1 and sutures the pancreatic parenchyma B1 and the jejunum B2 (S105).
  • the needles at both ends 920a to 920e known needles having a bioabsorbable absorbent thread (suture) and a biocompatible needle portion attached to both ends of the absorbent thread can be used.
  • the surgeon performs the anterior wall B1d of the pancreatic parenchyma B1 from the posterior wall B1c of the pancreatic parenchyma B1 (the dorsal portion of the pancreatic parenchyma B1 in the circumferential direction) and the portion arranged on the posterior wall B1c in the fusion promoting sheet 100.
  • Both ends needles 920a are moved toward (the ventral portion in the circumferential direction of the pancreatic parenchyma B1) and the portion arranged on the anterior wall B1d in the fusion promoting sheet 100.
  • the surgeon moves the needles 920a at both ends so as to insert the serosal muscular layer of the jejunum at the planned anastomosis site of the jejunum B2 (around the through hole B2a formed in the jejunum B2).
  • the operator repeats such an operation to insert a plurality of double-ended needles 920a to 920e into the jejunal serosal muscular layer of the fusion promoting sheet 100, the pancreatic parenchyma B1 and the jejunum B2.
  • the operator can fix the fusion promoting sheet 100 to the pancreatic parenchyma B1 by using a plurality of both end needles 920a to 920e that suture the pancreatic parenchyma B1 and the jejunum B2.
  • the number of both-end needles to be inserted into the jejunal serosal muscular layer of the pancreatic parenchyma B1 and the jejunum B2 and the position to insert the both-end needles are not particularly limited. Further, the surgeon may fix the fusion promoting sheet 100 to the pancreatic parenchyma B1 using biodegradable staples or the like as a fixing member instead of the plurality of double-ended needles 920a to 920e.
  • the operator ligates the needles 920a to 920e at both ends while pressing the jejunum B2 against the pancreatic parenchyma B1 with the operator's finger.
  • the pancreatic parenchyma B1 and the jejunum B2 are sutured with the fusion promoting sheet 100 sandwiched therein (see FIG. 26).
  • the jejunum B2 is deformed by the tension generated during suturing so as to wrap around the cut surface B1a of the pancreatic parenchyma B1 and the main body 110 of the fusion promoting sheet 100.
  • the operator can place the main body 110 of the fusion promoting sheet 100 between the cut surface B1a of the pancreatic parenchyma B1 and the intestinal wall of the jejunum B2.
  • the surgeon can place the medical device 200 as a so-called internal fistula tube between the pancreatic parenchyma B1 and the jejunum B2.
  • the main body 110 of the fusion promoting sheet 100 is placed between the cut surface B1a of the pancreatic parenchyma B1 and the intestinal wall of the jejunum B2 while being in contact with the cut surface B1a of the pancreatic parenchyma B1 and the intestinal wall of the jejunum B2.
  • the medical device 200 naturally falls off into the jejunum B2 after a predetermined period (several weeks to several months) has elapsed since the operator anastomosed the biological organ, and is led out of the body.
  • the treatment method according to the present embodiment is applied to the procedure for joining the pancreatic parenchyma B1 and the jejunum B2. Further, in the above-mentioned treatment method, the periphery of the cut surface B1a of the cut pancreatic parenchyma B1 and the intestinal wall (jejunal serosal muscular layer) of the jejunum B2 are joined. According to this treatment method, the biological tissue of the pancreatic parenchyma B1 and the biological tissue of the intestinal wall of the jejunum B2 are formed by the main body 110 of the fusion promoting sheet 100 sandwiched between the cut surface B1a of the pancreatic parenchyma B1 and the intestinal wall of the jejunum B2. Can promote fusion and reduce the risk of suture failure after pancreatic parenchymal-jejunostomy.
  • the fixing portions 220 may be arranged on both sides of the main body portion 210 in the axial direction X, as long as the fixing portions are easily locked in the living lumen in which the medical device is arranged.
  • the fixing portions 220 By providing the fixing portions 220 on both sides of the medical device 200A in this way, it can be expected that the fixing force of the medical device to the biological organ will increase (see FIG. 28).
  • each of the traction portions 250 for traction of the fixing portions 220 arranged on both sides of the main body portion 210 may be connected to each other. As a result, the operator can operate the fixing portions 220 arranged on both sides of the main body portion 210 at once.
  • the distance between one fixed portion and the other fixed portion is the height of the beam portion extending radially from the outer peripheral surface of the main body portion when the medical device is in the expanded state (t1 shown in FIG. 4). It is preferable that it is narrower. As a result, it is possible to suppress the possibility that each of the fixed portions repels the inner wall of the digestive tract and falls inward in the radial direction. Therefore, according to the fixing portion arranged in this way, it is possible to prevent the fixing force of the medical device from the gastrointestinal tract from being reduced during the procedure.
  • the main body portion is orthogonal to the axial direction X with each of the fixing portions as a starting point when an external force is applied by the traction portion. It may bend in a W shape when viewed from the direction in which it is used. According to the fixing portion arranged in this way, the outer shape of the medical device can be expanded, and it can be expected that the fixing force of the medical device to the digestive tract is further secured.
  • a tubular member (hereinafter referred to as an internal tube) may be further provided on the lumen of the main body portion.
  • the internal tube prevents the main body from bending in a W shape when viewed from the direction orthogonal to the axial direction X with each of the fixed parts as the starting point when an external force is applied by the traction part, and the pancreatic juice of the main body It can make it easier to pass through the lumen.
  • the internal tube can assist the fixing portion so that the external force is uniformly transmitted to the plurality of beam portions when the external force is applied by the traction portion. Therefore, the internal tube can uniformly expand the fixing portion to maintain the fixing force of the medical device.
  • the outer diameter of the inner tube is not particularly limited as long as it is smaller than the inner diameter of the main body.
  • the constituent material of the inner tube is not particularly limited as long as it can be composed of a material harder than the main body portion or the fixed portion.
  • the length of the inner tube with respect to the axial direction X is not particularly limited, but the end portion of the inner tube on the tip end side is on the tip end side of one fixing portion (fixed portion on the tip end side) arranged on the tip end side of the main body portion. It is preferable that the base end side end portion of the inner tube is arranged on the base end side of the other fixing portion (terminal side fixing portion) arranged on the base end side of one fixed portion.
  • the inner tube preferably extends from the connecting portion to the hole portion, and more preferably extends from the connecting portion to the fixing portion on the terminal side.
  • the method and position of connecting the internal tube to the main body are not particularly limited, but the internal tube may be connected to the main body at the connecting portion.
  • the inner surface of the main body and the outer surface of the inner tube may be coated with a lubricant such as silicone oil.
  • the lubricity of the inner tube with respect to the main body is improved, and the inner tube can move the lumen of the main body more smoothly. Therefore, the force required when the operator pulls the traction portion can be reduced.
  • the material that imparts slipperiness to the inner surface of the main body and the outer surface of the inner tube is not limited to the above-mentioned lubricating coating, and can be formed by combining materials having a small coefficient of friction.
  • the body portion is arranged so as to function as an internal fistula tube.
  • the body may be arranged to function as an external fistula tube.
  • the main body is arranged from the inside of the body to the outside of the body so as to penetrate the pancreatic parenchyma, the jejunum and the skin. Then, the pancreatic juice can be drained to the outside of the body by connecting the end portion of the main body toward the outside of the body to the drainage bag. The main body is pulled out of the body by the operator pulling the main body after a predetermined period of time has elapsed.
  • 1 Medical equipment set 100 fusion promotion sheet, 200 medical devices, 210 Main body (tubular member), 220 fixed part, 221 hole, 222 Beam, 230 operation unit, 240 Auxiliary part, 250 tow part, 260 connections, 270 hole (insertion hole), 280 locking part.

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgical Instruments (AREA)

Abstract

A medical instrument 200 according to the present invention has a main body portion 210 that is positioned between the pancreatic parenchyma B1 and the jejunum B2 and is equipped with a lumen L, and a fixing portion 220 that generates a fixing force for configuring the main body portion so as to be fixable to the pancreatic parenchyma B1, the fixing portion being configured so that the outer shape can be expanded by an external force.

Description

医療器具および医療器具セットMedical equipment and medical equipment set
 本発明は、医療器具および医療器具セットに関する。 The present invention relates to a medical device and a medical device set.
 一対の生体器官を外科的手術により接合する手技(例えば、消化管の吻合術)の一つとして、膵実質と空腸を接合する手技が知られている。膵頭部付近の腫瘍に対する処置方法の一つとして、膵頭部およびその周辺組織を切除する膵頭十二指腸切除が知られている。膵頭十二指腸切除後は、膵実質と空腸を接合する手技が行われる。 As one of the techniques for joining a pair of biological organs by surgical operation (for example, gastrointestinal anastomosis), a technique for joining the pancreatic parenchyma and the jejunum is known. Pancreaticoduodenectomy, in which the pancreatic head and its surrounding tissues are resected, is known as one of the treatment methods for tumors near the pancreatic head. After pancreaticoduodenectomy, a procedure is performed to join the pancreatic parenchyma and the jejunum.
 膵実質と空腸を接合する手技においては、例えば生分解性の縫合糸等の縫合部材により膵実質と空腸が縫合される。また、膵実質と空腸を接合する手技においては、膵管チューブ(例えば下記特許文献1参照)を用いて、膵実質と空腸が接合された接合部に膵管から排出される膵液が漏出することを抑制する場合がある。膵管チューブは、膵管チューブの一端部が膵管に挿入され、かつ、膵管チューブの他端部が空腸の内部等を経て体外に導出された状態で生体内に留置される。留置された膵管チューブは膵管から排出される膵液を体外へ排出することで接合部に漏出することを抑制する。 In the procedure for joining the pancreatic parenchyma and the jejunum, the pancreatic parenchyma and the jejunum are sutured by a suture member such as a biodegradable suture. In addition, in the procedure for joining the pancreatic parenchyma and the jejunum, a pancreatic duct tube (see, for example, Patent Document 1 below) is used to prevent pancreatic juice discharged from the pancreatic duct from leaking to the junction where the pancreatic parenchyma and the jejunum are joined. May be done. The pancreatic duct tube is placed in a living body in a state where one end of the pancreatic duct tube is inserted into the pancreatic duct and the other end of the pancreatic duct tube is led out to the outside of the body via the inside of the jejunum or the like. The indwelling pancreatic duct tube suppresses leakage to the joint by draining pancreatic juice discharged from the pancreatic duct to the outside of the body.
特開2007-167540号公報JP-A-2007-167540
本発明者らは、空腸と膵実質のように一対の消化管を簡便に接合できる医療器具について鋭意検討している。 The present inventors are diligently studying a medical device that can easily join a pair of gastrointestinal tracts such as the jejunum and the pancreatic parenchyma.
 そこで本発明は、一対の消化管を簡便に接合可能な医療器具を提供することを目的とする。 Therefore, an object of the present invention is to provide a medical device capable of easily joining a pair of digestive tracts.
 上記目的を達成する本発明に係る医療器具は、接合対象となる一対の消化管の間に配置され、ルーメンを備える管状部材と、少なくとも一方の消化管に対して前記管状部材を固定可能に構成するための固定力を生じさせる固定部と、を有し、前記固定部は、外力によって外形を拡張可能に構成される。 The medical device according to the present invention that achieves the above object is arranged between a pair of gastrointestinal tracts to be joined, and is configured so that the tubular member having a lumen and the tubular member can be fixed to at least one gastrointestinal tract. It has a fixing portion for generating a fixing force for the purpose, and the fixing portion is configured so that its outer shape can be expanded by an external force.
 本発明に係る医療器具および医療器具セットは、上記のように構成しているため、一対の消化管を簡便に接合させることができる。 Since the medical device and the medical device set according to the present invention are configured as described above, a pair of digestive tracts can be easily joined.
本発明の一実施形態に係る医療器具セットを示す図である。It is a figure which shows the medical device set which concerns on one Embodiment of this invention. 医療器具セットを構成する癒合促進シートの貫通孔について示す拡大断面図である。It is an enlarged cross-sectional view which shows the through hole of the fusion promotion sheet which constitutes a medical device set. 図1に係る医療器具の固定部を示すための側面図である。It is a side view for showing the fixed part of the medical device which concerns on FIG. 図1に係る医療器具の固定部の拡張状態を示すための側面図である。It is a side view for showing the expanded state of the fixed part of the medical device which concerns on FIG. 図4の5-5線に沿う拡大断面図である。FIG. 5 is an enlarged cross-sectional view taken along line 5-5 of FIG. 固定部を構成する孔部の変形例を示すための概略図である。It is the schematic for showing the modification of the hole part which constitutes a fixed part. 図6に係る医療器具の固定部の拡張状態を示すための断面図である。It is sectional drawing for showing the expanded state of the fixed part of the medical device which concerns on FIG. 固定部を構成する孔部の変形例を示すための概略図である。It is the schematic for showing the modification of the hole part which constitutes a fixed part. 固定部を構成する孔部の変形例を示すための概略図である。It is the schematic for showing the modification of the hole part which constitutes a fixed part. 図9に係る医療器具の固定部の拡張状態を示すための断面図である。FIG. 5 is a cross-sectional view for showing an expanded state of a fixed portion of the medical device according to FIG. 固定部を構成する孔部の変形例を示すための概略図である。It is the schematic for showing the modification of the hole part which constitutes a fixed part. 図11に係る医療器具の固定部の拡張状態を示すための側面図である。It is a side view for showing the expanded state of the fixed part of the medical device which concerns on FIG. 図1に係る医療器具の変形例1を示すための概略図である。It is a schematic diagram for showing the modification 1 of the medical device which concerns on FIG. 図13に係る医療器具の固定部の拡張状態を示すための側面図である。It is a side view for showing the expanded state of the fixed part of the medical device which concerns on FIG. 図1に係る医療器具の変形例2を示すための概略図である。It is a schematic diagram for showing the modification 2 of the medical device which concerns on FIG. 図15に係る医療器具の固定部の拡張状態を示すための概略図である。It is the schematic for showing the expanded state of the fixed part of the medical device which concerns on FIG. 図1に係る医療器具の変形例3を示すための概略図である。It is a schematic diagram for showing the modification 3 of the medical device which concerns on FIG. 図17に係る医療器具の固定部の拡張状態を示すための側面図である。It is a side view for showing the expanded state of the fixed part of the medical device which concerns on FIG. 医療デバイスを用いた処置方法の各手順を示すフローチャートである。It is a flowchart which shows each procedure of the treatment method using a medical device. 処置方法の実施形態(膵実質-空腸吻合術)の手順を示すフローチャートである。It is a flowchart which shows the procedure of embodiment (pancreatic parenchymal-jejunal anastomosis) of the treatment method. 膵実質-空腸吻合術を説明するための模式的な断面図である。FIG. 6 is a schematic cross-sectional view for explaining pancreatic parenchymal-jejunal anastomosis. 膵実質-空腸吻合術を説明するための模式的な断面図である。FIG. 6 is a schematic cross-sectional view for explaining pancreatic parenchymal-jejunal anastomosis. 膵実質-空腸吻合術を説明するための模式的な断面図である。FIG. 6 is a schematic cross-sectional view for explaining pancreatic parenchymal-jejunal anastomosis. 膵実質-空腸吻合術を説明するための模式的な斜視図である。It is a schematic perspective view for explaining a pancreatic parenchymal-jejunal anastomosis. 膵実質-空腸吻合術を説明するための模式的な斜視図である。It is a schematic perspective view for explaining a pancreatic parenchymal-jejunal anastomosis. 膵実質-空腸吻合術を説明するための模式的な断面図である。FIG. 6 is a schematic cross-sectional view for explaining pancreatic parenchymal-jejunal anastomosis. 医療器具の両端部に固定部が形成されている場合の医療器具セットを示す図である。It is a figure which shows the medical device set when the fixed part is formed at both ends of the medical device. 図27に示す医療器具セットを使用した膵実質-空腸吻合術を説明するための模式的な断面図である。FIG. 2 is a schematic cross-sectional view for explaining pancreatic parenchymal-jejunal anastomosis using the medical device set shown in FIG. 27.
 以下、添付した図面を参照しながら、本発明の実施形態を説明する。なお、以下の記載は特許請求の範囲に記載される技術的範囲や用語の意義を限定するものではない。また、図面の寸法比率は説明の都合上誇張されており、実際の比率とは異なる場合がある。 Hereinafter, embodiments of the present invention will be described with reference to the attached drawings. The following description does not limit the technical scope and meaning of terms described in the claims. In addition, the dimensional ratios in the drawings are exaggerated for convenience of explanation and may differ from the actual ratios.
 <第1実施形態>
 <医療器具セット1>
 図1は、本発明の一実施形態に係る医療器具セット1の説明に供する図である。
<First Embodiment>
<Medical equipment set 1>
FIG. 1 is a diagram provided for explaining a medical device set 1 according to an embodiment of the present invention.
 医療器具セット1は、図21~図26に示すように、所定の生体器官同士を接合する手技(例えば、消化管の吻合術)に適用することができる。後述するように、本明細書の説明では、医療器具セット1を使用した手技例として、膵実質B1と空腸B2を接合する膵実質-空腸吻合術を説明する。 As shown in FIGS. 21 to 26, the medical device set 1 can be applied to a procedure for joining predetermined biological organs (for example, gastrointestinal anastomosis). As will be described later, in the description of the present specification, a pancreatic parenchymal-jejunal anastomosis technique for joining the pancreatic parenchyma B1 and the jejunum B2 will be described as an example of a procedure using the medical device set 1.
 医療器具セット1は、癒合促進シート100と、医療器具200と、を有する。 The medical device set 1 has a fusion promoting sheet 100 and a medical device 200.
 <癒合促進シート100>
 図2は、医療器具セット1を構成する癒合促進シート100の貫通孔112について示す拡大断面図である。
<Union promotion sheet 100>
FIG. 2 is an enlarged cross-sectional view showing a through hole 112 of the fusion promoting sheet 100 constituting the medical device set 1.
 図1に示すように、癒合促進シート100は、複数の貫通孔112を有する生分解性シートから形成されるとともに生体組織の癒合を促進する本体部110を有している。 As shown in FIG. 1, the fusion promoting sheet 100 is formed of a biodegradable sheet having a plurality of through holes 112 and has a main body portion 110 that promotes fusion of living tissues.
 図1および図2に示すように、本体部110は、シート状の部材で構成している。 As shown in FIGS. 1 and 2, the main body 110 is composed of a sheet-shaped member.
 本体部110に形成された各貫通孔112は、図1および図2に示すように、本体部110の面方向において規則的かつ周期的に設けられている。ただし、各貫通孔112は、本体部110の面方向の各部においてランダムに設けられていてもよい。 As shown in FIGS. 1 and 2, each through hole 112 formed in the main body 110 is regularly and periodically provided in the plane direction of the main body 110. However, each through hole 112 may be randomly provided in each portion in the surface direction of the main body portion 110.
 各貫通孔112は、図2に示すように、本体部110の厚み方向(図2の上下方向)に沿って表面111と裏面113との間で略垂直に延びてている。なお、各貫通孔112は、本体部110の厚み方向に沿う断面において表面111と裏面113との間でジグザグ状に屈曲していたり、湾曲していたりしてもよい。 As shown in FIG. 2, each through hole 112 extends substantially vertically between the front surface 111 and the back surface 113 along the thickness direction of the main body 110 (vertical direction in FIG. 2). Each through hole 112 may be bent or curved in a zigzag shape between the front surface 111 and the back surface 113 in a cross section along the thickness direction of the main body 110.
 各貫通孔112は、略円形の平面形状(本体部110の表面111または本体部110の裏面113を平面視した際の形状)を有する。ただし、各貫通孔112の平面形状は、特に限定されず、例えば楕円形や多角形(矩形や三角形等)であってもよい。また、貫通孔112ごとに平面形状や断面形状が異なっていてもよい。 Each through hole 112 has a substantially circular planar shape (the shape when the front surface 111 of the main body 110 or the back surface 113 of the main body 110 is viewed in a plan view). However, the planar shape of each through hole 112 is not particularly limited, and may be, for example, an ellipse or a polygon (rectangle, triangle, etc.). Further, the plane shape and the cross-sectional shape may be different for each through hole 112.
 本体部110は、略円形の平面形状を有する。ただし、本体部110の平面形状は特に限定されず、例えば楕円形や多角形(矩形や三角形等)であってもよい。また、貫通孔112ごとに平面形状や断面形状が異なっていてもよい。 The main body 110 has a substantially circular planar shape. However, the planar shape of the main body 110 is not particularly limited, and may be, for example, an ellipse or a polygon (rectangle, triangle, etc.). Further, the plane shape and the cross-sectional shape may be different for each through hole 112.
 本体部110の厚み(図2に示す寸法T)は特に制限されないが、好ましくは0.05mm~0.3mmであり、より好ましくは0.1~0.2mmである。本体部110の厚みが0.05mm以上である場合(特に0.1mm以上である場合)、癒合促進シート100の取り扱い時に本体部110が破損しない程度の強度を備えさせることができる。一方、本体部110の厚みが0.3mm以下である場合(特に0.2mm以下である場合)、本体部110が適用される生体組織に本体部110が密着して生体組織に追随するのに十分な柔軟性を備えさせることができる。 The thickness of the main body 110 (dimension T shown in FIG. 2) is not particularly limited, but is preferably 0.05 mm to 0.3 mm, more preferably 0.1 to 0.2 mm. When the thickness of the main body 110 is 0.05 mm or more (particularly 0.1 mm or more), the strength is such that the main body 110 is not damaged when the fusion promoting sheet 100 is handled. On the other hand, when the thickness of the main body 110 is 0.3 mm or less (particularly 0.2 mm or less), the main body 110 adheres to the biological tissue to which the main body 110 is applied and follows the biological tissue. It can be provided with sufficient flexibility.
 本体部110は、貫通孔112のピッチP(図2に示すように、隣接する貫通孔112の間の距離)に対する貫通孔112の孔径Dの比の値が0.25以上40未満であることが好ましい。なお、貫通孔112の平面形状が真円である場合、貫通孔112の孔径Dは真円の直径に等しくなる。一方、貫通孔112の平面形状が真円でない場合には、貫通孔112の開口部(貫通孔112において表面111または裏面113に面した部分)の面積と同じ面積を有する真円の直径(円相当径)を当該貫通孔112の孔径Dとすることができる。 The main body 110 has a value of the ratio of the hole diameter D of the through hole 112 to the pitch P of the through hole 112 (distance between adjacent through holes 112 as shown in FIG. 2) of 0.25 or more and less than 40. Is preferable. When the planar shape of the through hole 112 is a perfect circle, the hole diameter D of the through hole 112 is equal to the diameter of the perfect circle. On the other hand, when the planar shape of the through hole 112 is not a perfect circle, the diameter of a perfect circle (circle) having the same area as the area of the opening of the through hole 112 (the portion of the through hole 112 facing the front surface 111 or the back surface 113). The equivalent diameter) can be the hole diameter D of the through hole 112.
 本体部110は、複数の貫通孔112を有するため、各貫通孔112に対応する孔径Dの値が複数存在する。そこで、本実施形態では、上述した比の値を算出するにあたっては、複数の貫通孔112にそれぞれ対応する孔径Dの値の2点以上の算術平均値を孔径Dの代表値として用いるものとする。一方、複数の貫通孔112のピッチPは、2つの貫通孔112の開口部同士の最短距離で定義する。ただし、ピッチPの値についても隣接する貫通孔112の組み合わせに対応するピッチPの値が複数存在する。したがって、本実施形態では、上述した比の値を算出するにあたっては、隣接する貫通孔112の組み合わせにそれぞれ対応するピッチPの値の2点以上の算術平均値をピッチPの代表値として用いるものとする。 Since the main body 110 has a plurality of through holes 112, there are a plurality of values of the hole diameter D corresponding to each through hole 112. Therefore, in the present embodiment, in calculating the above-mentioned ratio value, the arithmetic mean value of two or more points of the hole diameter D values corresponding to the plurality of through holes 112 is used as the representative value of the hole diameter D. .. On the other hand, the pitch P of the plurality of through holes 112 is defined by the shortest distance between the openings of the two through holes 112. However, as for the value of the pitch P, there are a plurality of values of the pitch P corresponding to the combination of the adjacent through holes 112. Therefore, in the present embodiment, in calculating the above-mentioned ratio value, the arithmetic mean value of two or more points of the pitch P values corresponding to the combinations of the adjacent through holes 112 is used as the representative value of the pitch P. And.
 なお、上記の貫通孔112のピッチP、孔径D、ピッチPに対する孔径Dの比等は一例であり、これに限定されることはない。 The pitch P, the hole diameter D, the ratio of the hole diameter D to the pitch P, and the like of the through hole 112 are examples, and are not limited thereto.
 本体部110は、生分解性の材料で構成することができる。本体部110の構成材料について特に制限はなく、例えば、生分解性樹脂が挙げられる。生分解性樹脂としては、例えば、特表2011-528275号公報、特表2008-514719号公報、国際公報第2008-1952号、特表2004-509205号公報等に記載されるものなどの公知の生分解性(共)重合体が使用できる。具体的には、(1)脂肪族ポリエステル、ポリエステル、ポリ酸無水物、ポリオルソエステル、ポリカーボネート、ポリホスファゼン、ポリリン酸エステル、ポリビニルアルコール、ポリペプチド、多糖、タンパク質、セルロースからなる群から選択される重合体;(2)上記(1)を構成する一以上の単量体から構成される共重合体などが挙げられる。すなわち、生分解性シートは、脂肪族ポリエステル、ポリエステル、ポリ酸無水物、ポリオルソエステル、ポリカーボネート、ポリホスファゼン、ポリリン酸エステル、ポリビニルアルコール、ポリペプチド、多糖、タンパク質、セルロースからなる群から選択される重合体、ならびに前記重合体を構成する一以上の単量体から構成される共重合体からなる群より選択される少なくとも一種の生分解性樹脂を含むことが好ましい。 The main body 110 can be made of a biodegradable material. The constituent material of the main body 110 is not particularly limited, and examples thereof include biodegradable resins. As the biodegradable resin, for example, those described in Japanese Patent Publication No. 2011-528275, Japanese Patent Publication No. 2008-514719, International Publication No. 2008-1952, Japanese Patent Publication No. 2004-509205 and the like are known. Biodegradable (co) polymers can be used. Specifically, it is selected from the group consisting of (1) aliphatic polyester, polyester, polyacid anhydride, polyorthoester, polycarbonate, polyphosphazene, polyphosphate ester, polyvinyl alcohol, polypeptide, polysaccharide, protein, and cellulose. Polymer; (2) A copolymer composed of one or more monomers constituting the above (1) and the like can be mentioned. That is, the biodegradable sheet is selected from the group consisting of aliphatic polyesters, polyesters, polyacid anhydrides, polyorthoesters, polycarbonates, polyphosphazenes, polyphosphates, polyvinyl alcohols, polypeptides, polysaccharides, proteins, and celluloses. It preferably contains at least one biodegradable resin selected from the group consisting of a polymer and a copolymer composed of one or more monomers constituting the polymer.
 本体部110の製造方法は特に限定されないが、例えば上述した生分解性樹脂からなる繊維を作製し、当該繊維を用いてメッシュ形状のシートを製造する方法が挙げられる。生分解性樹脂からなる繊維を作製する方法としては特に限定されないが、例えばエレクトロスピニング法(電界紡糸法・静電紡糸法)や、メルトブロー法等が挙げられる。本体部110は、上記方法のうち、1種のみを選択して用いてもよいし、2種以上を選択し適宜組み合わせてもよい。なお、本体部110の製造方法のさらに別の例として上述した生分解性樹脂からなる繊維を常法に従って紡糸し、得られた繊維をメッシュ状に編むことによって本発明に係る生分解性のシート部材を製造してもよい。 The manufacturing method of the main body 110 is not particularly limited, and examples thereof include a method of manufacturing a fiber made of the above-mentioned biodegradable resin and manufacturing a mesh-shaped sheet using the fiber. The method for producing the fiber made of a biodegradable resin is not particularly limited, and examples thereof include an electrospinning method (electrospinning method / electrostatic spinning method) and a melt blow method. As the main body 110, only one type may be selected and used from the above methods, or two or more types may be selected and appropriately combined. As yet another example of the method for manufacturing the main body 110, the biodegradable sheet according to the present invention is obtained by spinning the fibers made of the biodegradable resin described above according to a conventional method and knitting the obtained fibers into a mesh shape. Members may be manufactured.
 本体部110は、本体部110を構成する生分解性樹脂の構成材料によって生体反応を惹起させる。本体部110は、この作用により、フィブリン等の生体成分の発現を誘導する。このようにして誘導された生体成分は、本体部110の貫通孔112を貫通するようにして集積することで、癒合を促進することができる。したがって、膵実質B1と空腸B2の間に本体部110を配置することにより、上記のメカニズムによる癒合の促進が生じうる。 The main body 110 induces a biological reaction by the constituent material of the biodegradable resin constituting the main body 110. The main body 110 induces the expression of biological components such as fibrin by this action. The biological components induced in this way can promote fusion by accumulating so as to penetrate through the through hole 112 of the main body 110. Therefore, by arranging the main body 110 between the pancreatic parenchyma B1 and the jejunum B2, promotion of fusion by the above mechanism can occur.
 なお、癒合促進シート100の材質は、生体器官の癒合を促進させることができれば生分解性でなくてもよい。また、癒合促進シート100は、生体器官の癒合を促進させることができれば、材質にかかわらず、貫通孔112が形成されていなくてもよい。 The material of the fusion promoting sheet 100 does not have to be biodegradable as long as it can promote the fusion of biological organs. Further, the fusion promoting sheet 100 may not have a through hole 112 formed regardless of the material, as long as it can promote the fusion of living organs.
 <医療器具200>
 次に、医療器具200について説明する。医療器具200は膵実質B1と空腸B2のように、接合対象となる一対の消化管の管腔が連通した状態を維持する際に用いられる。図3~図12は、医療器具200の説明に供する図である。
<Medical device 200>
Next, the medical device 200 will be described. The medical device 200 is used to maintain a state in which the lumens of the pair of gastrointestinal tracts to be joined are in communication, such as the pancreatic parenchyma B1 and the jejunum B2. 3 to 12 are diagrams for explaining the medical device 200.
 なお、以下の説明において、空腸B2に挿入され得る医療器具200の一端部側を「基端側」、膵実質B1に挿入され得る医療器具200の他端部側を「先端側」と称す。また、先端側から基端側に向かう方向(またはその逆方向)を軸方向Xと称する。 In the following description, the one end side of the medical device 200 that can be inserted into the jejunum B2 is referred to as the "base end side", and the other end side of the medical device 200 that can be inserted into the pancreatic parenchyma B1 is referred to as the "tip side". Further, the direction from the tip end side to the base end side (or the opposite direction) is referred to as an axial direction X.
 医療器具200は、接合対象となる消化管(膵実質B1と空腸B2)の間に配置される本体部210(「管状部材」に相当する)と、少なくとも一方の消化管(膵実質B1)に対して本体部210を固定可能に構成するための固定力を生じさせる固定部220と、外力を固定部220に伝えることによって固定部220を変形させる操作部230と、操作部230が固定部220に外力を伝えている状態を維持する補助部240と、を有する。 The medical device 200 is attached to the main body 210 (corresponding to a “tubular member”) arranged between the digestive tracts (pancreatic parenchyma B1 and jejunum B2) to be joined, and at least one gastrointestinal tract (pancreatic parenchyma B1). On the other hand, the fixing portion 220 that generates a fixing force for forming the main body portion 210 so that it can be fixed, the operating portion 230 that deforms the fixing portion 220 by transmitting an external force to the fixing portion 220, and the operating portion 230 that the operating portion 230 fixes the fixing portion 220. It has an auxiliary unit 240 that maintains a state in which an external force is transmitted to the pancreas.
 <本体部210>
 本体部210は、ルーメンLを備える。本実施形態において中空断面の形状を真円や楕円等の円形状として構成している。本体部210の外径r1および内径は特に限定されないが、好ましくは3Fr(外径1.0mm、内径0.5mm)~15Fr(外径5.0mm、内径3.0mm)であり、より好ましくは4Fr(外径1.3mm、内径0.7mm)~6Fr(外径2.0mm、内径1.4mm)である。
<Main body 210>
The main body 210 includes a lumen L. In the present embodiment, the shape of the hollow cross section is configured as a circular shape such as a perfect circle or an ellipse. The outer diameter r1 and inner diameter of the main body 210 are not particularly limited, but are preferably 3 Fr (outer diameter 1.0 mm, inner diameter 0.5 mm) to 15 Fr (outer diameter 5.0 mm, inner diameter 3.0 mm), and more preferably. It is 4 Fr (outer diameter 1.3 mm, inner diameter 0.7 mm) to 6 Fr (outer diameter 2.0 mm, inner diameter 1.4 mm).
 本体部210は、膵実質B1と空腸B2の間に配置されると、先端側開口部210AからルーメンLに膵液を導入し、基端側開口部210Bから空腸B2へ該膵液を排液する。 When the main body 210 is arranged between the pancreatic parenchyma B1 and the jejunum B2, the pancreatic juice is introduced into the lumen L from the distal opening 210A, and the pancreatic juice is drained from the proximal opening 210B to the jejunum B2.
 本体部210は、弾性を有する非生分解性の材料で構成することができる。本体部210は、術者が消化管を吻合して本体部210を生体内に留置してから所定の期間(数週間~数か月)が経過した後に、自然に空腸B2に脱落し、体外に導出される。すなわち、本体部210は、いわゆる内瘻チューブとして機能する。 The main body 210 can be made of an elastic, non-biodegradable material. The main body 210 spontaneously falls off into the jejunum B2 after a predetermined period (weeks to months) has passed since the operator anastomosed the digestive tract and placed the main body 210 in the living body, and the main body 210 was in vitro. Derived to. That is, the main body 210 functions as a so-called internal fistula tube.
 本体部210は、図1、図3に示すように、先端側に少なくとも一つの側孔210Pを備える。側孔210Pは、膵実質B1と空腸B2の間に配置されると、膵液をルーメンLに導入し空腸B2へ排液する。そのため、側孔210Pは、先端側開口部210Aが閉塞した場合も膵液を空腸B2へ排液することができる。 As shown in FIGS. 1 and 3, the main body 210 is provided with at least one side hole 210P on the tip side. When the side hole 210P is arranged between the pancreatic parenchyma B1 and the jejunum B2, the pancreatic juice is introduced into the lumen L and drained into the jejunum B2. Therefore, the side hole 210P can drain pancreatic juice into the jejunum B2 even when the distal end side opening 210A is occluded.
 本体部210の構成材料について特に制限はなく、例えば、塩化ビニル、ポリウレタンエラストマー、ポリスチレンエラストマー、スチレン-エチレン-ブチレン-スチレン共重合体(SEBS)、スチレン-エチレン-プロピレン-スチレン共重合体(SEPS)などの熱可塑性エラストマー、ナイロン、PETなどの熱可塑性樹脂、又はゴム、シリコーンエラストマー等で構成することができる。 The constituent materials of the main body 210 are not particularly limited, and are, for example, vinyl chloride, polyurethane elastomer, polystyrene elastomer, styrene-ethylene-butylene-styrene copolymer (SEBS), styrene-ethylene-propylene-styrene copolymer (SEPS). It can be composed of a thermoplastic elastomer such as, nylon, a thermoplastic resin such as PET, rubber, a silicone elastomer or the like.
 <固定部220>
 固定部220は、図3、図4に示すように、本体部210の先端側の一定の領域に設けられている複数の孔部221と、孔部221の各々の間にそれぞれ配置される複数の梁部222と、によって構成される。
<Fixed part 220>
As shown in FIGS. 3 and 4, the fixing portions 220 are a plurality of holes 221 provided in a certain area on the tip end side of the main body 210, and a plurality of fixed portions 220 arranged between the holes 221 respectively. It is composed of a beam portion 222 of the above.
 図4に示すように、固定部220が外力によって軸方向Xに圧縮されると、梁部222の各々を放射方向(径方向)外向きに折り曲がることによって、医療器具200の外形(外径r1)を円形状(放射状)に拡張させることができる(図5を参照)。 As shown in FIG. 4, when the fixing portion 220 is compressed in the axial direction X by an external force, each of the beam portions 222 is bent outward in the radial direction (diameter direction), whereby the outer diameter (outer diameter) of the medical instrument 200 is obtained. r1) can be expanded into a circular shape (radial) (see FIG. 5).
 孔部221の各々は、図4、図5、図7、図10に示すように、放射方向(径方向)外向きに折り曲がることによって、露出面221mを露出させる。 As shown in FIGS. 4, 5, 7, and 10, each of the holes 221 is bent outward in the radial direction (diameter direction) to expose the exposed surface 221 m.
 固定部220は、医療器具200の外径r1を拡張させることによって、膵管B1bの内壁を押し広げて、膵実質B1に対する医療器具200の嵌合力(抵抗力)を高めることができる。そのため、固定部220は、膵管B1bに対して本体部210を固定することができる。 By expanding the outer diameter r1 of the medical device 200, the fixing portion 220 can expand the inner wall of the pancreatic duct B1b to increase the fitting force (resistance force) of the medical device 200 with respect to the pancreatic parenchyma B1. Therefore, the fixing portion 220 can fix the main body portion 210 to the pancreatic duct B1b.
 術者は、膵管B1bに医療器具200を一度挿入し、固定部220によって膵管B1bに対して本体部210を固定すると、医療器具200が膵実質B1の管腔(膵管B1b)に挿入されている状態を維持することができる。また、術者は、医療器具200を膵管B1bから抜き差しすることなく、膵実質B1の切断面B1aの周囲(前壁B1dと後壁B1c)と空腸B2とを運針して、膵実質B1と空腸B2を接合することができる。そのため、術者は、膵管B1bと空腸B2とを縫合することなく、膵実質B1と空腸B2の吻合を行うことができ、膵実質B1と空腸B2とを簡便に接合させることができる。 The surgeon inserts the medical device 200 into the pancreatic duct B1b once, fixes the main body 210 to the pancreatic duct B1b by the fixing portion 220, and the medical device 200 is inserted into the cavity of the pancreatic parenchyma B1 (pancreatic duct B1b). The state can be maintained. Further, the surgeon moves the circumference of the cut surface B1a of the pancreatic parenchyma B1 (anterior wall B1d and posterior wall B1c) and the jejunum B2 without inserting and removing the medical device 200 from the pancreatic duct B1b, and moves the pancreatic parenchyma B1 and the jejunum. B2 can be joined. Therefore, the operator can perform anastomosis between the pancreatic parenchyma B1 and the jejunum B2 without suturing the pancreatic duct B1b and the jejunum B2, and can easily join the pancreatic parenchyma B1 and the jejunum B2.
 孔部221および梁部222は、図5に示すように、それぞれ8か所設けられている。また、孔部221の各々(および梁部222の各々)は、固定部220の周方向θに対して所定の間隔をおいて設けられている。なお、孔部221および梁部222の数は特に限定されず、好ましくはそれぞれ2~16か所、より好ましくはそれぞれ4~8か所設けられている。 As shown in FIG. 5, the hole portion 221 and the beam portion 222 are each provided at eight locations. Further, each of the hole portions 221 (and each of the beam portions 222) is provided at a predetermined interval with respect to the circumferential direction θ of the fixed portion 220. The number of holes 221 and beam 222 is not particularly limited, and preferably 2 to 16 holes, more preferably 4 to 8 holes, respectively.
 孔部221は、本体部210に形成された直線状の切れ目(スリット)である。孔部221の長手方向に沿う各々の長さkは、図3に示すように同一または略同一であり、好ましくは3~8mmである。孔部221の作成方法は、特に限定されないが、例えば、レーザー加工によって作成することができる。 The hole portion 221 is a linear cut (slit) formed in the main body portion 210. Each length k of the hole 221 along the longitudinal direction is the same or substantially the same as shown in FIG. 3, preferably 3 to 8 mm. The method for producing the hole 221 is not particularly limited, but the hole 221 can be produced, for example, by laser processing.
 孔部221は、図3に示すように、軸方向Xに交差するように形成される。軸方向Xに対する孔部221の傾斜角度θ1(軸方向Xに対する孔部221の起点221aから終点221bまでの仮想線m1の傾斜角度)は、好ましくは0~89°、より好ましくは17~45°である。 As shown in FIG. 3, the hole portion 221 is formed so as to intersect in the axial direction X. The inclination angle θ1 of the hole portion 221 with respect to the axial direction X (the inclination angle of the virtual line m1 from the start point 221a to the end point 221b of the hole portion 221 with respect to the axial direction X) is preferably 0 to 89 °, more preferably 17 to 45 °. Is.
 また、固定部220の拡張後の外径r2(図4を参照)は、膵管B1bの内径に対して、2~4倍であることが好ましい。膵管B1bの内径が2mmである場合、固定部220の拡張後の外径r2は、好ましくは4~8mmであり、より好ましくは5mmである。 Further, the outer diameter r2 (see FIG. 4) of the fixed portion 220 after expansion is preferably 2 to 4 times the inner diameter of the pancreatic duct B1b. When the inner diameter of the pancreatic duct B1b is 2 mm, the outer diameter r2 of the fixed portion 220 after expansion is preferably 4 to 8 mm, more preferably 5 mm.
 術者は、孔部221の長さkや傾斜角度θ1を調整することによって、固定部220の拡径後の外径r2を変更し、消化管に対して本体部210を固定可能に構成するための固定力(以下、医療器具200の固定力と称する)を調整することができる。 By adjusting the length k and the inclination angle θ1 of the hole 221, the surgeon changes the outer diameter r2 after the diameter of the fixing portion 220 is expanded so that the main body 210 can be fixed to the digestive tract. (Hereinafter referred to as the fixing force of the medical device 200) can be adjusted.
 医療器具200の拡張後の固定力は、拡張前に対して1.1~4倍であることが好ましい。なお、該固定力とは、膵実質B1に医療器具200を挿入し、固定部220によって医療器具200の外径r1を拡張した後に、医療器具200の基端側を鉗子などでつかんで一定の速度で引っ張った時の最大強度である。拡張前の固定力が1.2~1.7Nである場合、拡張後の固定力は2~5Nであることが好ましい。 The fixing force of the medical device 200 after expansion is preferably 1.1 to 4 times that before expansion. The fixing force is constant after inserting the medical device 200 into the pancreatic parenchyma B1 and expanding the outer diameter r1 of the medical device 200 by the fixing portion 220, and then grasping the proximal end side of the medical device 200 with forceps or the like. Maximum strength when pulled at speed. When the fixing force before expansion is 1.2 to 1.7N, the fixing force after expansion is preferably 2 to 5N.
 また、孔部221は直線状であると説明したが、孔部221の形状は特に限定されない。孔部221は、例えば、楕円の円弧のような曲線状(図6を参照)であってもよい。孔部221の形状を楕円の円弧のような曲線状にすることによって、固定部220が外力によって軸方向Xに圧縮されたときの軸方向Xから視た梁部222の形状を調整することができる(図5、図7を参照)。そのため、術者は、膵管B1bの内壁と梁部222との接触量(接触箇所)を調整し、消化管に対する医療器具200の固定力を調整することができる。 Further, although it was explained that the hole portion 221 is linear, the shape of the hole portion 221 is not particularly limited. The hole 221 may have a curved shape (see FIG. 6) such as an elliptical arc. By making the shape of the hole 221 curved like an elliptical arc, it is possible to adjust the shape of the beam portion 222 as seen from the axial direction X when the fixed portion 220 is compressed in the axial direction X by an external force. Yes (see FIGS. 5 and 7). Therefore, the operator can adjust the contact amount (contact point) between the inner wall of the pancreatic duct B1b and the beam portion 222, and adjust the fixing force of the medical device 200 to the digestive tract.
 また、孔部221は、複数の直線を組み合わせてなる折れ線状(図8を参照)であってもよい。仮想線m1に対する孔部221の起点221a側の角度(傾斜角度θ2)は、仮想線m1に対する孔部221の終点221b側の角度(傾斜角度θ3)より大きいことが好ましい。この場合、梁部222は、外力によって軸方向Xに圧縮されると、軸方向Xに直交する方向から視たときに基端側に傾斜して折り曲がる。そのため、固定部220は、消化管に対する医療器具200の固定力をより生じさせることが期待できる。 Further, the hole portion 221 may have a polygonal line shape (see FIG. 8) formed by combining a plurality of straight lines. The angle (inclination angle θ2) of the hole portion 221 with respect to the virtual line m1 on the start point 221a side is preferably larger than the angle (inclination angle θ3) of the end point 221b side of the hole portion 221 with respect to the virtual line m1. In this case, when the beam portion 222 is compressed in the axial direction X by an external force, the beam portion 222 is inclined and bent toward the proximal end side when viewed from a direction orthogonal to the axial direction X. Therefore, the fixing portion 220 can be expected to generate more fixing force of the medical device 200 to the digestive tract.
 また、孔部221は螺旋状であってもよい。 Further, the hole 221 may be spiral.
 また、孔部221が延在する方向は特に限定されない。 Further, the direction in which the hole 221 extends is not particularly limited.
 また、孔部221の各々の配置は特に限定されない。図4に示すように、孔部221の起点221a(または終点221b)各々は、本体部210の周方向θに揃って(本体部210の軸方向Xに対して同じ位置に)配置されていてもよく、図9に示すように、ジグザグ状に(本体部210の軸方向Xに対して互いに異なる位置に)配置されていてもよい。 Further, the arrangement of each of the holes 221 is not particularly limited. As shown in FIG. 4, each of the start point 221a (or end point 221b) of the hole portion 221 is arranged so as to be aligned with the circumferential direction θ of the main body portion 210 (at the same position with respect to the axial direction X of the main body portion 210). Alternatively, as shown in FIG. 9, they may be arranged in a zigzag shape (positions different from each other with respect to the axial direction X of the main body 210).
 図9に示すように、孔部221の各々が本体部210の軸方向Xに対して互いに異なる位置に配置されている場合、固定部220は、外力によって軸方向Xに圧縮されると、図10に示すように、医療器具200の外形を略矩形状に拡張させることができる。 As shown in FIG. 9, when each of the hole portions 221 is arranged at different positions with respect to the axial direction X of the main body portion 210, the fixing portion 220 is compressed in the axial direction X by an external force. As shown in FIG. 10, the outer shape of the medical device 200 can be expanded into a substantially rectangular shape.
 また、図11に示すように、梁部222の基端側には、孔部221より長さの短い1つ以上の孔部223が形成されていてもよい。梁部222の基端側は、孔部223が形成されることによって、孔部223が形成されていない先端側より柔軟性を有する。そのため、梁部222は、外力によって軸方向Xに圧縮されると、軸方向Xに直交する方向から視て、孔部221が形成されている位置(軸方向Xに対する孔部221の起点221aの位置を示す仮想線m2から終点221bを示す仮想線m3まで間)より基端側に傾斜して折り曲がる(図12を参照)。そのため、固定部220は、消化管に対する医療器具200の固定力をより生じさせることが期待できる。 Further, as shown in FIG. 11, one or more hole portions 223 having a length shorter than that of the hole portion 221 may be formed on the base end side of the beam portion 222. The base end side of the beam portion 222 is more flexible than the tip end side where the hole portion 223 is not formed due to the formation of the hole portion 223. Therefore, when the beam portion 222 is compressed in the axial direction X by an external force, the beam portion 222 is at a position where the hole portion 221 is formed (the starting point 221a of the hole portion 221 with respect to the axial direction X) when viewed from a direction orthogonal to the axial direction X. From the virtual line m2 indicating the position to the virtual line m3 indicating the end point 221b), the beam is inclined toward the base end and bent (see FIG. 12). Therefore, the fixing portion 220 can be expected to generate more fixing force of the medical device 200 to the digestive tract.
 <操作部230、補助部240>
 操作部230は、図1、図3、図4に示すように、牽引されることによって固定部220に外力を付与する牽引部250と、本体部210に対する牽引部250の接続を可能にする接続部260と、を有している。また、補助部240は、図4に示すように、接続部260を起点として本体部210のルーメンLに少なくとも部分的に挿通した牽引部250を外部に露出させる孔部270(「挿通孔」に相当する)と、牽引部250の少なくとも一部を孔部270に係止可能に構成される係止部280と、を有している。
<Operation unit 230, auxiliary unit 240>
As shown in FIGS. 1, 3, and 4, the operation unit 230 is a connection that enables the connection between the towing unit 250 that applies an external force to the fixing unit 220 by being towed and the towing unit 250 to the main body unit 210. It has a part 260 and. Further, as shown in FIG. 4, the auxiliary portion 240 has a hole portion 270 (“insertion hole”) that exposes the traction portion 250 that is at least partially inserted into the lumen L of the main body portion 210 starting from the connection portion 260. Correspondingly), and a locking portion 280 configured so that at least a part of the traction portion 250 can be locked to the hole portion 270.
 牽引部250は、所定の長さであって、本体部210のルーメンLや孔部270に挿通可能な断面形状を備える長尺状の部材(例えば、細径な紐状の部材や所定の幅を有する帯状の部材)で構成することができる。なお、牽引部250の長さ等について特に制限はない。 The traction portion 250 has a predetermined length and has a long-shaped member having a cross-sectional shape that can be inserted into the lumen L of the main body portion 210 and the hole portion 270 (for example, a small-diameter string-shaped member or a predetermined width). It can be composed of a band-shaped member having the above. There is no particular limitation on the length of the towed portion 250 and the like.
 接続部260は、本体部210の先端に形成されている。牽引部250の基端を本体部210の先端側に固定する方法は特に限定されないが、縫合や接着剤によって固定したり、融着等を用いて接続したり、牽引部250の一端を輪っか状に結んで本体部210の先端に引掛けたりすることができる。 The connection portion 260 is formed at the tip of the main body portion 210. The method of fixing the base end of the traction portion 250 to the tip end side of the main body portion 210 is not particularly limited, but it can be fixed by suture or adhesive, connected by fusion or the like, or one end of the traction portion 250 has a ring shape. It can be tied to and hooked on the tip of the main body 210.
 孔部270は、本体部210に形成され、先端部に形成された固定部220より基端側(本体部210の一端部側に形成された固定部220より中央側)に配置されている。本実施形態における牽引部250は、本体部210の先端に形成されている接続部260から本体部210の基端側に形成されている孔部270までの本体部210のルーメンLに挿通し、牽引されることによって固定部220に外力を付与することができる。そのため、術者は、固定部220に直接的に外力を与えることなく、固定部220を変形させることができる。また、術者は、孔部270が本体部210の側面に設けられていることによって、手技にあわせて牽引部250を牽引する位置を調整することができる。 The hole 270 is formed in the main body 210 and is arranged on the base end side (center side from the fixed portion 220 formed on one end side of the main body 210) with respect to the fixed portion 220 formed at the tip end. The traction portion 250 in the present embodiment is inserted into the lumen L of the main body portion 210 from the connection portion 260 formed at the tip of the main body portion 210 to the hole portion 270 formed on the base end side of the main body portion 210. An external force can be applied to the fixed portion 220 by being pulled. Therefore, the operator can deform the fixed portion 220 without directly applying an external force to the fixed portion 220. Further, the operator can adjust the position of pulling the towing portion 250 according to the procedure by providing the hole portion 270 on the side surface of the main body portion 210.
 術者は、牽引部250の少なくとも一部を本体部210のルーメンLに挿通した状態で、牽引部250を牽引する(牽引部250に軸方向X張力を付与する)ことによって、固定部220に外力を付与し、固定部220を軸方向Xに圧縮させることができる。 The surgeon pulls the traction portion 250 (applies axial X tension to the traction portion 250) with at least a part of the traction portion 250 inserted through the lumen L of the main body portion 210 to the fixed portion 220. An external force can be applied to compress the fixing portion 220 in the axial direction X.
 係止部280は、牽引部250の一定の範囲に設けられている1つ以上の突起である。係止部280の各々は、弾性を有する材料で構成され、牽引部250に所定以上の張力が付与されると弾性変形することによって孔部270を通過したり(乗り越えたり)、孔部270に係止したりすることができる。なお、該突起の形状(断面形状)は特に限定されず、例えば、棘状(鋭利な形状が直線によって形成されている状態)であってもよく、鎌状(鋭利な形状が部分的に曲線によって形成されている状態)であってもよく、球形状(牽引部250を玉結びすることによって形成されている状態)であってもよい。 The locking portion 280 is one or more protrusions provided in a certain range of the traction portion 250. Each of the locking portions 280 is made of an elastic material, and when a tension of a predetermined value or more is applied to the traction portion 250, the locking portion 280 elastically deforms to pass through (overcome) the hole portion 270 or to the hole portion 270. It can be locked. The shape (cross-sectional shape) of the protrusion is not particularly limited, and may be, for example, a spine shape (a state in which a sharp shape is formed by a straight line) or a sickle shape (a sharp shape is partially curved). It may be in a spherical shape (a state formed by tying a traction portion 250).
 術者は、牽引部250を牽引するときに牽引部250に設けられている係止部280のいずれかを孔部270に係止させることによって、牽引部250を牽引している状態(以下、牽引状態と称する)を維持することができる。したがって、術者は、牽引部250を牽引していない(操作部230を操作していない間)も、係止部280によって固定部が外形を拡張させている状態(以下、拡張状態と称する)を維持することができる。 The operator is pulling the towing portion 250 by locking any of the locking portions 280 provided in the towing portion 250 to the hole portion 270 when the towing portion 250 is towed (hereinafter, referred to as a state). It can maintain a traction state). Therefore, the operator is in a state in which the fixed portion expands the outer shape by the locking portion 280 even when the traction portion 250 is not towed (while the operating portion 230 is not being operated) (hereinafter referred to as an expanded state). Can be maintained.
 なお、牽引部250の材料は、ルーメンLに挿通された状態で牽引されたときに、固定部220を軸方向Xに圧縮させることが可能である限り、特に限定されない。 The material of the traction portion 250 is not particularly limited as long as the fixing portion 220 can be compressed in the axial direction X when the traction portion 250 is towed while being inserted through the lumen L.
 牽引部250が生分解性の材料で構成されている場合、牽引部250が生体内で分解されると、牽引部250の強度が低下する。そして、本体部210に対する牽引部250の牽引力が低下する(牽引状態が解除される)。そして、固定部220は、本体部210の弾性力によって、拡張状態(梁部222の各々を放射方向外向きに折り曲げている状態)から自然状態(梁部222の各々が折り曲がっていない状態)に戻る。そのため、膵実質B1に対する医療器具200の固定力が減弱し、医療器具200が自然に空腸B2内に脱落可能となる。 When the traction portion 250 is made of a biodegradable material, the strength of the traction portion 250 decreases when the traction portion 250 is decomposed in a living body. Then, the traction force of the traction portion 250 with respect to the main body portion 210 is reduced (the traction state is released). The fixed portion 220 is changed from an expanded state (a state in which each of the beam portions 222 is bent outward in the radial direction) to a natural state (a state in which each of the beam portions 222 is not bent) due to the elastic force of the main body portion 210. Return to. Therefore, the fixing force of the medical device 200 to the pancreatic parenchyma B1 is weakened, and the medical device 200 can naturally fall into the jejunum B2.
 また、牽引部250の構成材料について特に制限はなく、例えば、塩化ビニル、ポリウレタンエラストマー、ポリスチレンエラストマー、スチレン-エチレン-ブチレン-スチレン共重合体(SEBS)、スチレン-エチレン-プロピレン-スチレン共重合体(SEPS)などの熱可塑性エラストマー、ナイロン、PETなどの熱可塑性樹脂、又はゴム、シリコーンエラストマー等で構成することができる。 Further, the constituent material of the traction portion 250 is not particularly limited, and for example, vinyl chloride, polyurethane elastomer, polystyrene elastomer, styrene-ethylene-butylene-styrene copolymer (SEBS), styrene-ethylene-propylene-styrene copolymer (Styrene-ethylene-propylene-styrene copolymer). It can be composed of a thermoplastic elastomer such as SEPS), a thermoplastic resin such as nylon or PET, or a rubber or silicone elastomer.
 また、牽引部250の断面形状や細さは、消化管の吻合を阻害しない限り、特に制限はない。 Further, the cross-sectional shape and thinness of the traction portion 250 are not particularly limited as long as they do not interfere with the anastomosis of the digestive tract.
 また、牽引部250は、接続部260に固定される一端部とは反対の他端部に生体適合性を備える針部を有していてもよい。これにより、術者は、牽引部250で空腸B2の漿膜上で縫合固定し、空腸B2と膵実質B1を近づけることができる。 Further, the traction portion 250 may have a needle portion having biocompatibility at the other end portion opposite to the one end portion fixed to the connection portion 260. Thereby, the operator can suture and fix the jejunum B2 on the serosa of the jejunum B2 at the traction portion 250 to bring the jejunum B2 and the pancreatic parenchyma B1 close to each other.
 また、係止部280は、孔部270側に設けられていてもよい。孔部270には、たとえば、弁体や切り込みを設けることができる。係止部280は、牽引部250の少なくとも一部を挟み込むことによって牽引状態を維持することができる。係止部280が孔部270側に設けられた弁体である場合、術者が牽引部250に所定以上の張力を付与したときに係止部280を弾性変形させることによって、牽引部250を進退可能に構成することができる。また、係止部280が孔部270側に設けられた切り込み(スリット)である場合、術者が牽引部250に所定以上の張力を付与したときに係止部280を切り込みから外すことによって、牽引部250を進退可能に構成することができる。 Further, the locking portion 280 may be provided on the hole portion 270 side. The hole 270 may be provided with, for example, a valve body or a notch. The locking portion 280 can maintain the traction state by sandwiching at least a part of the traction portion 250. When the locking portion 280 is a valve body provided on the hole portion 270 side, the traction portion 250 is elastically deformed when the operator applies a tension equal to or higher than a predetermined value to the traction portion 250. It can be configured to be able to move forward and backward. Further, when the locking portion 280 is a notch (slit) provided on the hole portion 270 side, the locking portion 280 is removed from the notch when the operator applies a tension equal to or higher than a predetermined value to the traction portion 250. The traction unit 250 can be configured to be able to move forward and backward.
 また、係止部280の材料は、弾性を有する限り特に制限はないが、生分解性の材料で構成することが好ましい。係止部280が生体内で分解されると、牽引状態が解除される。したがって、膵実質B1に対する医療器具200の固定力が減弱し、医療器具200が自然に空腸B2内に脱落可能となる。なお、係止部280が生分解性の材料で構成されている場合、牽引部250は非生分解性の材料で構成されていてもよい。 The material of the locking portion 280 is not particularly limited as long as it has elasticity, but it is preferably composed of a biodegradable material. When the locking portion 280 is decomposed in the living body, the traction state is released. Therefore, the fixing force of the medical device 200 to the pancreatic parenchyma B1 is weakened, and the medical device 200 can naturally fall into the jejunum B2. When the locking portion 280 is made of a biodegradable material, the traction portion 250 may be made of a non-biodegradable material.
 係止部280の構成材料について特に制限はなく、例えば、塩化ビニル、ポリウレタンエラストマー、ポリスチレンエラストマー、スチレン-エチレン-ブチレン-スチレン共重合体(SEBS)、スチレン-エチレン-プロピレン-スチレン共重合体(SEPS)などの熱可塑性エラストマー、ナイロン、PETなどの熱可塑性樹脂、又はゴム、シリコーンエラストマー等で構成することができる。 The constituent material of the locking portion 280 is not particularly limited, and for example, vinyl chloride, polyurethane elastomer, polystyrene elastomer, styrene-ethylene-butylene-styrene copolymer (SEBS), styrene-ethylene-propylene-styrene copolymer (SEPS). ) And the like, a thermoplastic resin such as nylon and PET, rubber, a silicone elastomer and the like.
 また、係止部280の形状は、弾性変形によって本体部210の孔部270を通過したり、孔部270に係止したりことができる限り、特に制限はない。また、係止部280の各々の形状は、互いに同一であってもよく、異なっていてもよい。 Further, the shape of the locking portion 280 is not particularly limited as long as it can pass through the hole 270 of the main body 210 or be locked in the hole 270 by elastic deformation. Further, the shapes of the locking portions 280 may be the same as or different from each other.
 また、本実施形態に係る医療器具200は、前述したように、本体部210と固定部220と操作部230と補助部240とを備えていると説明したが、本体部210と固定部220と操作部230で構成してもよい。また、牽引部250は、本体部210と一体的に構成されていなくてもよい。この場合、術者は、手技に際し、医療器具200とは別に牽引部250を準備する。術者は、手技の進行等に応じて、医療器具200と牽引部250とを適宜組み合わせて使用することができる。 Further, as described above, the medical device 200 according to the present embodiment has been described as having the main body 210, the fixing 220, the operating 230, and the auxiliary 240, but the main body 210 and the fixing 220 It may be configured by the operation unit 230. Further, the tow portion 250 does not have to be integrally formed with the main body portion 210. In this case, the surgeon prepares the traction portion 250 separately from the medical device 200 during the procedure. The surgeon can use the medical device 200 and the traction portion 250 in an appropriate combination according to the progress of the procedure and the like.
 以上説明したように本実施形態に係る医療器具200は、膵実質B1と空腸B2(接合対象となる一対の消化管)の間に配置され、ルーメンLを備える本体部210(管状部材)と、膵実質B1(少なくとも一方の消化管)に対して本体部210を固定可能に構成するための固定力を生じさせる固定部220と、を有し、固定部220は、外力によって外形(外径r1)を拡張可能に構成される。 As described above, the medical device 200 according to the present embodiment is arranged between the pancreatic parenchyma B1 and the jejunum B2 (a pair of gastrointestinal tracts to be joined), and has a main body 210 (tubular member) having a lumen L and a main body portion 210 (tubular member). It has a fixing portion 220 that generates a fixing force for forming the main body portion 210 so as to be able to be fixed to the pancreatic parenchyma B1 (at least one gastrointestinal tract), and the fixing portion 220 has an outer shape (outer diameter r1) by an external force. ) Is extensible.
 上記医療器具200によれば、固定部220は、医療器具200の外形(外径r1)を拡張させることによって、膵管B1bの内壁を押し広げて、膵実質B1に対する医療器具200の嵌合力(抵抗力)を高めることができる。そのため、固定部220は、膵管B1bに対して本体部210を固定することができる。したがって、術者は、膵管B1bに医療器具200を一度挿入し、固定部220によって膵管B1bに対して本体部210を固定すると、医療器具200が膵実質B1の管腔(膵管B1b)に挿入されている状態を維持することができる。また、術者は、医療器具200を膵管B1bから抜き差しすることなく、膵実質B1の切断面B1aの周囲(前壁B1dと後壁B1c)と空腸B2とを運針して、膵実質B1と空腸B2を接合することができる。そのため、術者は、膵管B1bと空腸B2とを縫合することなく、膵実質B1と空腸B2の吻合を行うことができ、膵実質B1と空腸B2とを簡便に接合させることができる。 According to the medical device 200, the fixing portion 220 expands the inner wall of the pancreatic duct B1b by expanding the outer shape (outer diameter r1) of the medical device 200, and the fitting force (resistance) of the medical device 200 to the pancreatic parenchyma B1. Power) can be increased. Therefore, the fixing portion 220 can fix the main body portion 210 to the pancreatic duct B1b. Therefore, when the operator inserts the medical device 200 into the pancreatic duct B1b once and fixes the main body 210 to the pancreatic duct B1b by the fixing portion 220, the medical device 200 is inserted into the cavity of the pancreatic parenchyma B1 (pancreatic duct B1b). Can be maintained. Further, the surgeon moves the circumference of the cut surface B1a of the pancreatic parenchyma B1 (anterior wall B1d and posterior wall B1c) and the jejunum B2 without inserting and removing the medical device 200 from the pancreatic duct B1b, and moves the pancreatic parenchyma B1 and the jejunum. B2 can be joined. Therefore, the operator can perform anastomosis between the pancreatic parenchyma B1 and the jejunum B2 without suturing the pancreatic duct B1b and the jejunum B2, and can easily join the pancreatic parenchyma B1 and the jejunum B2.
 また、医療器具200は、外力を固定部220に伝えることによって固定部220を変形させる操作部230を備える。そのため、術者は、膵実質B1と空腸B2とを簡便に接合させることができる。 Further, the medical device 200 includes an operation unit 230 that deforms the fixed portion 220 by transmitting an external force to the fixed portion 220. Therefore, the operator can easily join the pancreatic parenchyma B1 and the jejunum B2.
 また、操作部230は、牽引されることによって固定部220に外力を付与し、固定部220を軸方向Xに圧縮させる牽引部250と、本体部210に対する牽引部250の接続を可能にする接続部260と、を備える。そのため、術者は、固定部220に直接的に外力を与えることなく、固定部220を変形させることができる。 Further, the operation unit 230 is a connection that enables the connection between the traction unit 250 that applies an external force to the fixing unit 220 by being pulled and compresses the fixing unit 220 in the axial direction X and the traction unit 250 to the main body unit 210. A unit 260 is provided. Therefore, the operator can deform the fixed portion 220 without directly applying an external force to the fixed portion 220.
 また、医療器具200は、操作部230が固定部220に外力を伝えている状態を維持する補助部240をさらに備える。そのため、術者は、操作部230を操作していない間も、医療器具200の拡張状態を維持することができる。 Further, the medical device 200 further includes an auxiliary unit 240 that maintains a state in which the operating unit 230 transmits an external force to the fixed unit 220. Therefore, the operator can maintain the expanded state of the medical device 200 even when the operation unit 230 is not operated.
 また、補助部240は、本体部210に形成され、本体部210の先端側(軸方向Xの端部)に形成された固定部220より基端側(本体部210の一端部側に形成された固定部220より中央側)に配置され、牽引部250をルーメンLに挿入した状態において牽引部250を外部に露出させる孔部270(挿通孔)と、牽引部250および孔部270の少なくとも一方に設けられ、牽引部250の少なくとも一部を孔部270に係止可能に構成される係止部280と、を備える。そのため、術者は、牽引部250を牽引するときに、牽引部250に設けられている係止部280のいずれかを本体部210の孔部270に係止させることによって、牽引状態を維持することができる。したがって、術者は、係止部280によって、医療器具200の拡張状態を維持することができる。 Further, the auxiliary portion 240 is formed on the main body portion 210, and is formed on the base end side (one end side of the main body portion 210) from the fixed portion 220 formed on the tip end side (end portion in the axial direction X) of the main body portion 210. A hole 270 (insertion hole) that is arranged on the central side of the fixed portion 220 and exposes the traction portion 250 to the outside when the traction portion 250 is inserted into the lumen L, and at least one of the traction portion 250 and the hole portion 270. The locking portion 280 is provided in the above and is configured so that at least a part of the traction portion 250 can be locked in the hole portion 270. Therefore, when the traction portion 250 is towed, the operator maintains the traction state by locking any of the locking portions 280 provided on the traction portion 250 to the hole 270 of the main body portion 210. be able to. Therefore, the operator can maintain the expanded state of the medical device 200 by the locking portion 280.
 また、固定部220は、本体部210の先端側(軸方向Xの端部)に設けられている複数の孔部221と、孔部221の各々の間にそれぞれ配置される複数の梁部222とを有し、固定部220は、牽引部250によって軸方向Xに圧縮されると、梁部222の各々を放射方向外向きに折り曲げることによって、外径r1を拡張させる。医療器具200の外形(外径r1)を拡張させることによって、膵管B1bの内壁を押し広げて、膵実質B1に対する医療器具200の嵌合力(抵抗力)を高めることができる。そのため、固定部220は、膵管B1bに対して本体部210を固定することができる。 Further, the fixing portion 220 includes a plurality of hole portions 221 provided on the tip end side (end portion in the axial direction X) of the main body portion 210, and a plurality of beam portions 222 arranged between each of the hole portions 221. When the fixed portion 220 is compressed in the axial direction X by the traction portion 250, the fixed portion 220 expands the outer diameter r1 by bending each of the beam portions 222 outward in the radial direction. By expanding the outer shape (outer diameter r1) of the medical device 200, the inner wall of the pancreatic duct B1b can be expanded to increase the fitting force (resistance) of the medical device 200 to the pancreatic parenchyma B1. Therefore, the fixing portion 220 can fix the main body portion 210 to the pancreatic duct B1b.
 また、医療器具セット1は、上述した医療器具200と、膵実質B1と空腸B2の間に配置されることにより膵実質B1と空腸B2の癒合を促進する癒合促進シート100と、を有する。このように構成することによって、一対の消化管を接合する手技において、術後における縫合不全のリスクを低減させることができるとともに、手技中に膵管B1bからの膵液の漏出を抑制しつつ、簡便に膵実質B1と空腸B2を接合できる。 Further, the medical device set 1 has the above-mentioned medical device 200 and a fusion promoting sheet 100 that promotes fusion between the pancreatic parenchyma B1 and the jejunum B2 by being arranged between the pancreatic parenchyma B1 and the jejunum B2. With this configuration, it is possible to reduce the risk of postoperative suture failure in the procedure of joining a pair of gastrointestinal tracts, and it is easy to suppress the leakage of pancreatic juice from the pancreatic duct B1b during the procedure. The pancreatic parenchyma B1 and the jejunum B2 can be joined.
 次に、第1実施形態に係る医療器具200の変形例1~3について説明する。なお、変形例1~3の説明において、上述した医療器具200と共通する構成には同一の符号を付し、その説明を適宜省略する。また、変形例の説明で特に説明がない内容については、前述した実施形態と同一のものとすることができる。 Next, modifications 1 to 3 of the medical device 200 according to the first embodiment will be described. In the description of the modified examples 1 to 3, the same reference numerals are given to the configurations common to the medical device 200 described above, and the description thereof will be omitted as appropriate. Further, the contents that are not particularly explained in the description of the modified example can be the same as those in the above-described embodiment.
 <変形例1>
 図13、図14は、変形例1に係る医療器具300の説明に供する図である。
<Modification example 1>
13 and 14 are views provided for explaining the medical device 300 according to the first modification.
 医療器具300は、接合対象となる消化管(膵実質B1と空腸B2)の間に配置される本体部210と、少なくとも一方の消化管(膵実質B1)に対して本体部210を固定可能に構成するための固定力を生じさせる固定部320と、外力を固定部320に伝えることによって固定部320を変形させる操作部330と、を有する。 The medical device 300 can fix the main body 210 to the gastrointestinal tract (pancreatic parenchyma B1 and jejunum B2) to be joined and to at least one gastrointestinal tract (pancreatic parenchyma B1). It has a fixing portion 320 that generates a fixing force for forming, and an operating portion 330 that deforms the fixing portion 320 by transmitting an external force to the fixing portion 320.
 図13に示すように、変形例1に係る固定部320は、本体部210の先端側の一定の領域に設けられている複数の孔部321と、本体部210の内部に部分的に収容され、外力によって軸方向Xに圧縮されると孔部321の各々から突出可能な複数のワイヤ322の先端側と、によって構成されていてもよい。 As shown in FIG. 13, the fixing portion 320 according to the first modification is partially housed in a plurality of holes 321 provided in a certain area on the tip end side of the main body portion 210 and inside the main body portion 210. It may be composed of a plurality of wires 322 that can protrude from each of the holes 321 when compressed in the axial direction X by an external force.
 また、変形例1に係る操作部330は、本体部210の基端側に突出するように設けられ、本体部210の先端側に向かって押し込むことが可能に構成されるワイヤ322の基端側によって構成されていてもよい。 Further, the operation unit 330 according to the first modification is provided so as to project toward the base end side of the main body portion 210, and can be pushed toward the tip end side of the main body portion 210 on the base end side of the wire 322. It may be composed of.
 変形例1に係るワイヤ322の先端側は、本体部210の内周壁と外周壁との間に設けられている凹部に収容されている。また、ワイヤ322の基端側は、本体部210の基端側に突出するように設けられいる。また、該凹部は、孔部321に連通している。そのため、ワイヤ322は、部分的に孔部321に沿うように、本体部210に挿入されている。 The tip end side of the wire 322 according to the first modification is housed in a recess provided between the inner peripheral wall and the outer peripheral wall of the main body 210. Further, the base end side of the wire 322 is provided so as to project toward the base end side of the main body 210. Further, the recess communicates with the hole 321. Therefore, the wire 322 is inserted into the main body 210 so as to partially follow the hole 321.
 術者が操作部330を操作する(本体部210の基端側に突出しているワイヤ322を先端側に押し込む)と、図14に示すように、ワイヤ322は軸方向Xに圧縮されて放射方向(径方向)外向きに折り曲がる。そして、ワイヤ322の折れ曲がった部分が孔部321から突出する。このように、術者は、ワイヤ322に外力を付与することによって、医療器具300の外形(外径)を円形状(放射状)に拡張させることができる。 When the operator operates the operation unit 330 (the wire 322 protruding toward the base end side of the main body 210 is pushed toward the tip end side), the wire 322 is compressed in the axial direction X and in the radial direction as shown in FIG. (Diameter) Bend outward. Then, the bent portion of the wire 322 protrudes from the hole portion 321. In this way, the operator can expand the outer shape (outer diameter) of the medical device 300 into a circular shape (radial) by applying an external force to the wire 322.
 術者は、孔部321の長さやワイヤ322の長さを調整することによって、固定部320の拡径後の外径や、ワイヤ322が変形した後の形状を変更し、消化管に対する医療器具300の固定力を調整することができる。 By adjusting the length of the hole 321 and the length of the wire 322, the surgeon changes the outer diameter of the fixed portion 320 after the diameter is expanded and the shape of the wire 322 after the wire 322 is deformed, and is a medical device for the digestive tract. The fixing force of 300 can be adjusted.
 ワイヤ322は、弾塑性または形状記憶性を有し、生分解性を有する合金であることが好ましく、例えば、Mg、またはMgを主成分とする合金で構成することができる。ワイヤ322は、弾塑性または形状記憶性を有しているため、外力によって変形した後の形状を維持することができる。したがって、医療器具300は拡張状態を維持することができる。また、ワイヤ322は、生分解性を有しているため、生体内で分解されると強度が低下する。そのため、医療器具300は、生体内に留置されてから所定期間が経過すると拡張状態を解除し、自然に空腸B2内に脱落可能となる。 The wire 322 is preferably an alloy having elasto-plasticity or shape memory and having biodegradability, and can be composed of, for example, Mg or an alloy containing Mg as a main component. Since the wire 322 has elasto-plasticity or shape memory, it can maintain its shape after being deformed by an external force. Therefore, the medical device 300 can maintain the expanded state. Further, since the wire 322 has biodegradability, its strength decreases when it is decomposed in a living body. Therefore, the medical device 300 is released from the expanded state after a predetermined period of time has passed since it was placed in the living body, and can be naturally dropped into the jejunum B2.
 <変形例2>
 図15、図16は、変形例2に係る医療器具400の説明に供する図である。
<Modification 2>
15 and 16 are diagrams for explaining the medical device 400 according to the second modification.
 医療器具400は、接合対象となる消化管(膵実質B1と空腸B2)の間に配置される本体部210と、少なくとも一方の消化管(膵実質B1)に対して本体部210を固定可能に構成するための固定力を生じさせる固定部420と、外力を固定部420に伝えることによって固定部420を変形させる操作部430と、を有する。 The medical device 400 can fix the main body 210 to the gastrointestinal tract (pancreatic parenchyma B1 and jejunum B2) to be joined and to at least one gastrointestinal tract (pancreatic parenchyma B1). It has a fixing portion 420 that generates a fixing force for construction, and an operating portion 430 that deforms the fixing portion 420 by transmitting an external force to the fixing portion 420.
 図15に示すように、変形例2に係る固定部420は、後述する操作部430と本体部210の先端側に接続され、本体部210の周囲を螺旋状に巻回するように設けられているワイヤ421によって構成されていてもよい。 As shown in FIG. 15, the fixing portion 420 according to the modified example 2 is connected to the tip end side of the operation portion 430 and the main body portion 210, which will be described later, and is provided so as to spirally wind around the main body portion 210. It may be composed of a wire 421.
 また、変形例2に係る操作部430は、本体部210の基端側に設けられ、本体部210の周方向θに対して回転可能に構成された把持部によって構成されていてもよい。 Further, the operation unit 430 according to the second modification may be provided by a grip portion provided on the base end side of the main body portion 210 and rotatably configured in the circumferential direction θ of the main body portion 210.
 術者が操作部430を操作する(ワイヤ421の巻き方向と反対側に回転させる)と、図16に示すように、ワイヤ421の巻き径が拡大する。そのため、術者は、ワイヤ421に外力を付与することによって、医療器具400の外形(外径)を拡張させることができる。 When the operator operates the operation unit 430 (rotates the wire 421 in the direction opposite to the winding direction), the winding diameter of the wire 421 increases as shown in FIG. Therefore, the operator can expand the outer shape (outer diameter) of the medical device 400 by applying an external force to the wire 421.
 術者は、操作部430の操作量を調整することによって、固定部420の拡径後の外径を変更し、消化管に対する医療器具400の固定力を調整することができる。 By adjusting the amount of operation of the operation unit 430, the operator can change the outer diameter of the fixing unit 420 after the expansion and adjust the fixing force of the medical device 400 to the digestive tract.
 ワイヤ421は、変形例1のワイヤ322と同様の材料で構成することができる。 The wire 421 can be made of the same material as the wire 322 of the first modification.
 また、ワイヤ421の断面形状は、特に限定されない。ワイヤ421には、部分的に突起が設けられていてもよく、ワイヤ421は、該突起によって膵実質B1に対する嵌合力(抵抗力)をより高めることができる。 Further, the cross-sectional shape of the wire 421 is not particularly limited. The wire 421 may be partially provided with protrusions, and the protrusions can further increase the fitting force (resistance force) to the pancreatic parenchyma B1.
 なお、操作部430と本体部210との接続部分の形態は特に限定されない。例えば、操作部430は部分的に本体部210のルーメンLに挿入されていてもよい。また、操作部430と本体部210の接続方法は特に限定されず、例えば、本体部210のルーメンLに突起などを設けることによって、本体部210と操作部430とを接続させることができる。該突起は、本体部210と同じ材料で構成してもよく、異なる材料で構成してもよいが、例えば、生分解性を有する材料や、水溶性を有する材料によって構成することができる。このように構成することによって、該突起が生体内で分解されると、本体部210のルーメンLが拡張される。そのため、膵管B1bからの膵液を空腸B2へ排出する排出経路をより確保することができる。 The form of the connection portion between the operation unit 430 and the main body 210 is not particularly limited. For example, the operation unit 430 may be partially inserted into the lumen L of the main body unit 210. Further, the method of connecting the operation unit 430 and the main body 210 is not particularly limited, and for example, the main body 210 and the operation unit 430 can be connected by providing a protrusion or the like on the lumen L of the main body 210. The protrusion may be made of the same material as the main body 210, or may be made of a different material, but may be made of, for example, a biodegradable material or a water-soluble material. With this configuration, when the protrusion is decomposed in the living body, the lumen L of the main body 210 is expanded. Therefore, it is possible to further secure an excretion route for discharging pancreatic juice from the pancreatic duct B1b to the jejunum B2.
 <変形例3>
 図17、図18は、変形例3に係る医療器具500の説明に供する図である。
<Modification example 3>
17 and 18 are views provided for explaining the medical device 500 according to the third modification.
 医療器具500は、接合対象となる消化管(膵実質B1と空腸B2)の間に配置される本体部510と、少なくとも一方の消化管(膵実質B1)に対して本体部510を固定可能に構成するための固定力を生じさせる固定部520と、外力を固定部520に伝えることによって固定部520を変形させる操作部530と、を有する。 The medical device 500 can fix the main body 510 arranged between the digestive tracts (pancreatic parenchyma B1 and jejunum B2) to be joined and the main body 510 to at least one gastrointestinal tract (pancreatic parenchyma B1). It has a fixing portion 520 that generates a fixing force for construction, and an operating portion 530 that deforms the fixing portion 520 by transmitting an external force to the fixing portion 520.
 変形例3に係る本体部510は、弾塑性または形状記憶性を有し、生分解性を有する合金であることが好ましく、例えば、Mg、またはMgを主成分とする合金で構成されている。 The main body 510 according to the third modification is preferably an alloy having elasto-plasticity or shape memory and biodegradability, and is composed of, for example, Mg or an alloy containing Mg as a main component.
 図17に示すように、変形例3に係る固定部520は、本体部510の先端側の一定の領域に設けられている複数の孔部521と、孔部521の各々の間にそれぞれ配置される複数の梁部522と、によって構成されていてもよい。 As shown in FIG. 17, the fixing portion 520 according to the modified example 3 is arranged between a plurality of hole portions 521 provided in a certain region on the tip end side of the main body portion 510 and each of the hole portions 521. It may be composed of a plurality of beam portions 522.
 変形例3に係る操作部530は、本体部510の基端側の一定の領域を把持部として用いることによって構成されていてもよい。 The operation unit 530 according to the modification 3 may be configured by using a certain area on the base end side of the main body unit 510 as a grip portion.
 術者が操作部530を操作する(本体部510の基端側をひねる)と、図18に示すように、固定部520は螺旋状に変形し、梁部522は放射方向(径方向)外向きに折り曲がる。このように、術者は、固定部520に外力を付与することによって、医療器具500の外形(外径)を拡張させることができる。 When the operator operates the operation portion 530 (twists the base end side of the main body portion 510), the fixing portion 520 is spirally deformed and the beam portion 522 is outside the radial direction (diameter direction) as shown in FIG. Bend in the direction. In this way, the operator can expand the outer shape (outer diameter) of the medical device 500 by applying an external force to the fixed portion 520.
 術者は、孔部321の長さや傾斜角度を調整することによって、固定部320の拡径後の外径や、軸方向Xから視たときの外形を変更し、消化管に対する医療器具200の固定力を調整することができる。 By adjusting the length and inclination angle of the hole 321, the surgeon can change the outer diameter of the fixed portion 320 after expansion and the outer diameter when viewed from the axial direction X, and the surgeon can change the outer diameter of the medical device 200 for the digestive tract. The fixing force can be adjusted.
 <処置方法の実施形態(生体器官吻合術)>
 次に、医療器具セットを用いた処置方法を説明する。
<Example of treatment method (living organ anastomosis)>
Next, a treatment method using a medical device set will be described.
 図19は、医療器具セットを用いた処置方法の各手順を示すフローチャートである。 FIG. 19 is a flowchart showing each procedure of the treatment method using the medical device set.
 処置方法は、生体器官の接合対象となる一方の被接合部位と他方の被接合部位の間に医療器具を配置すること(S11)、生体組織の癒合を促進するシート状の本体部を備える癒合促進シートを医療器具に挿通させ、一方の被接合部位に医療器具を固定すること(S12)、一方の被接合部位と他方の被接合部位との間に癒合促進シートの本体部の少なくとも一部を配置した状態で一方の被接合部位と他方の被接合部位とを接合すること(S13)、を含む。 The treatment method is to place a medical instrument between one joint site to be joined and the other joint site to be joined (S11), and to have a sheet-shaped main body that promotes fusion of biological tissues. Inserting the promotion sheet through the medical device and fixing the medical device to one of the jointed parts (S12), at least a part of the main body of the fusion promoting sheet between one of the joined parts and the other of the joined parts. Includes joining (S13) between one joined portion and the other joined portion in a state where the above is arranged.
 処置方法により接合される生体器官および生体器官における被接合部位は特に限定されず、任意に選択することができる。以下の説明では、膵実質-空腸吻合術を例に挙げて説明する。また、以下に説明する各手技において使用される医療器具セットとしては、例えば、前述した医療器具セットの中から任意のものを選択することが可能であるし、その他の医療器具セットを選択することもできる。ただし、以下の説明では、各手技に好適に用いることができる代表的な例として、図1に示した医療器具セット1の使用例を説明する。また、以下に説明する各手技において、公知の手技手順や公知の医療装置・医療器具等については詳細な説明を適宜省略する。 The living organ to be joined by the treatment method and the jointed part in the living organ are not particularly limited and can be arbitrarily selected. In the following description, pancreatic parenchymal-jejunal anastomosis will be described as an example. Further, as the medical device set used in each procedure described below, for example, any one can be selected from the above-mentioned medical device sets, and other medical device sets can be selected. You can also. However, in the following description, a usage example of the medical device set 1 shown in FIG. 1 will be described as a typical example that can be suitably used for each procedure. Further, in each procedure described below, detailed description of known procedure procedures and known medical devices / instruments will be omitted as appropriate.
 以下、本明細書の説明において「生体器官の間に癒合促進シート(または医療器具)を配置する」とは、生体器官に癒合促進シート(または医療器具)が直接的にまたは間接的に接触した状態で配置されること、生体器官との間に空間的な隙間が形成された状態で癒合促進シート(または医療器具)が配置されること、またはその両方の状態で癒合促進シート(または医療器具)が配置されること(例えば、一方の生体器官に癒合促進シート(または医療器具)が接触し、他方の生体器官には癒合促進シート(または医療器具)が接触していない状態で配置されること)の少なくとも一つを意味する。また、本明細書の説明において「周辺」とは、厳密な範囲(領域)を規定するものではなく、処置の目的(生体器官同士の接合)を達成し得る限りにおいて、所定の範囲(領域)を意味する。また、各処置方法において説明する手技手順は、処置の目的を達成し得る限りにおいて、順番を適宜入れ替えることが可能である。また、本明細書の説明において「相対的に接近させる」とは、接近させる対象となる2つ以上のものを、互いに接近させること、一方のみを他方のみに接近させることの両方を意味する。 Hereinafter, in the description of the present specification, "arranging a fusion promoting sheet (or medical device) between living organs" means that the healing promoting sheet (or medical device) comes into direct or indirect contact with the living organ. The fusion-promoting sheet (or medical device) is placed in a state, the fusion-promoting sheet (or medical device) is placed in a state where a spatial gap is formed between the living organs, or both. ) Is placed (for example, one biological organ is in contact with the fusion promoting sheet (or medical device), and the other biological organ is not in contact with the healing promoting sheet (or medical device). That means at least one of them. Further, in the description of the present specification, the term "periphery" does not define a strict range (region), but a predetermined range (region) as long as the purpose of treatment (bonding between biological organs) can be achieved. Means. In addition, the order of the procedure procedures described in each treatment method can be changed as appropriate as long as the purpose of the treatment can be achieved. Further, in the description of the present specification, "relatively approaching" means both bringing two or more objects to be approached close to each other and bringing only one close to the other.
 <処置方法の実施形態(膵実質-空腸吻合術)>
 図20は、処置方法の実施形態(膵実質-空腸吻合術)の手順を示すフローチャートであり、図21~図26は、膵実質-空腸吻合術の説明に供する図である。
<Example of treatment method (pancreatic parenchyma-jejunal anastomosis)>
FIG. 20 is a flowchart showing the procedure of the embodiment of the treatment method (pancreatic parenchymal-jejunal anastomosis), and FIGS. 21 to 26 are diagrams used for explaining the pancreatic parenchymal-jejunal anastomosis.
 本実施形態に係る処置方法において、接合対象となる生体器官は、膵頭十二指腸切除後の膵実質B1と、空腸B2である。以下の説明では、切断した膵実質B1の切断面B1a周辺(一方の被接合部位)と空腸B2の腸壁の任意の部位(他方の被接合部位)を接合する手順を説明する。 In the treatment method according to the present embodiment, the biological organs to be joined are the pancreatic parenchyma B1 after pancreaticoduodenectomy and the jejunum B2. In the following description, a procedure for joining the periphery of the cut surface B1a of the cut pancreatic parenchyma B1 (one joined site) and an arbitrary site of the intestinal wall of the jejunum B2 (the other joined site) will be described.
 図20に示すように、本実施形態に係る処置方法は、癒合促進シート100と、医療器具200とを有する医療器具セット1を準備すること(S101)、医療器具200を膵管B1bに挿入して配置すること(S102)、癒合促進シート100を医療器具200に取り付けること(S103)、医療器具200を空腸B2に挿入すること(S104)、膵実質B1と空腸B2とを縫合すること(S105)、を含む。 As shown in FIG. 20, the treatment method according to the present embodiment is to prepare a medical device set 1 having a fusion promoting sheet 100 and a medical device 200 (S101), and insert the medical device 200 into the pancreatic duct B1b. Arrangement (S102), attachment of the fusion promotion sheet 100 to the medical device 200 (S103), insertion of the medical device 200 into the jejunum B2 (S104), stitching of the pancreatic parenchyma B1 and the jejunum B2 (S105). ,including.
 次に、図21~図26を参照して、本実施形態に係る処置方法の一例を具体的に説明する。なお、図26では、後述する複数の両端針920a~920eを省略している。 Next, an example of the treatment method according to the present embodiment will be specifically described with reference to FIGS. 21 to 26. In FIG. 26, a plurality of needles at both ends 920a to 920e, which will be described later, are omitted.
 まず、術者は、癒合促進シート100と、医療器具200と、を有する医療器具セット1を準備する(S101)。 First, the surgeon prepares a medical device set 1 having a fusion promoting sheet 100 and a medical device 200 (S101).
 次に、図21に示すように、術者は、医療器具200を本体部210の先端側(図1に示す先端側開口部210A側)から膵管B1bに挿入する。そして、術者は、医療器具200を膵実質B1に対して固定しうる(S102)。このとき、術者は、牽引部250を牽引して、固定部220を軸方向Xに圧縮させることによって、固定部220の外形(外径r1)を拡張することができる(図22を参照)。また、術者は、牽引部250に形成されている係止部280を本体部210の孔部270に係止させることによって、本体部210に対する牽引部250の牽引力を維持することができる。そのため、術者は、膵管B1bに対する医療器具200の位置を固定部220によって固定することができる。 Next, as shown in FIG. 21, the operator inserts the medical device 200 into the pancreatic duct B1b from the distal end side of the main body 210 (the distal end side opening 210A side shown in FIG. 1). The surgeon can then fix the medical device 200 to the pancreatic parenchyma B1 (S102). At this time, the operator can expand the outer shape (outer diameter r1) of the fixed portion 220 by pulling the towed portion 250 and compressing the fixed portion 220 in the axial direction X (see FIG. 22). .. Further, the operator can maintain the traction force of the traction portion 250 with respect to the main body portion 210 by locking the locking portion 280 formed in the traction portion 250 to the hole portion 270 of the main body portion 210. Therefore, the operator can fix the position of the medical device 200 with respect to the pancreatic duct B1b by the fixing portion 220.
 次に、図23に示すように、術者は、癒合促進シート100に孔部120(図1を参照)を形成して医療器具200に取り付ける(S103)。なお、術者が孔部120を形成する際に使用するデバイスは特に限定されない。また、孔部120は、使用前の状態であらかじめ癒合促進シート100に形成されていてもよい。また、術者は、癒合促進シート100の孔部120に医療器具200を挿通させた後に、医療器具200を膵管B1bに挿入してもよい。 Next, as shown in FIG. 23, the operator forms a hole 120 (see FIG. 1) in the fusion promoting sheet 100 and attaches it to the medical device 200 (S103). The device used by the operator when forming the hole 120 is not particularly limited. Further, the hole 120 may be formed in the fusion promoting sheet 100 in advance in a state before use. Further, the surgeon may insert the medical device 200 into the pancreatic duct B1b after inserting the medical device 200 into the hole 120 of the fusion promoting sheet 100.
 次に、術者は、本体部210の基端側(図1に示す基端側開口部210B側)を空腸B2に挿入する(S104)。これによって、膵管B1bからの膵液を空腸B2へ排出する排出経路が形成され(図26を参照)、膵管B1bからの膵液が膵実質B1と空腸B2の被接合部位に漏出することを抑制することができる。 Next, the operator inserts the proximal end side of the main body 210 (the proximal end side opening 210B side shown in FIG. 1) into the jejunum B2 (S104). As a result, a drainage route for draining pancreatic juice from the pancreatic duct B1b to the jejunum B2 is formed (see FIG. 26), and the pancreatic juice from the pancreatic duct B1b is suppressed from leaking to the junction between the pancreatic parenchyma B1 and the jejunum B2. Can be done.
 次に、術者は、図24に示すように、癒合促進シート100を膵実質B1の切断面B1aに配置し、膵実質B1と空腸B2とを縫合する(S105)。なお、以下の説明では、複数の両端針920a~920eを固定部材として用いて癒合促進シート100を膵実質B1に固定する手順の一例を説明する。両端針920a~920eとしては、生体吸収性を備える吸収糸(縫合糸)と、吸収糸の両端に取り付けられた生体適合性を備える針部と、を有する公知のものを用いることができる。 Next, as shown in FIG. 24, the operator places the fusion promoting sheet 100 on the cut surface B1a of the pancreatic parenchyma B1 and sutures the pancreatic parenchyma B1 and the jejunum B2 (S105). In the following description, an example of a procedure for fixing the fusion promoting sheet 100 to the pancreatic parenchyma B1 by using a plurality of both end needles 920a to 920e as fixing members will be described. As the needles at both ends 920a to 920e, known needles having a bioabsorbable absorbent thread (suture) and a biocompatible needle portion attached to both ends of the absorbent thread can be used.
 まず、術者は、膵実質B1の後壁B1c(膵実質B1の周方向の背側の部分)および癒合促進シート100において後壁B1c上に配置された部分から、膵実質B1の前壁B1d(膵実質B1の周方向の腹側の部分)および癒合促進シート100において前壁B1d上に配置された部分に向かって、両端針920aを運針する。 First, the surgeon performs the anterior wall B1d of the pancreatic parenchyma B1 from the posterior wall B1c of the pancreatic parenchyma B1 (the dorsal portion of the pancreatic parenchyma B1 in the circumferential direction) and the portion arranged on the posterior wall B1c in the fusion promoting sheet 100. Both ends needles 920a are moved toward (the ventral portion in the circumferential direction of the pancreatic parenchyma B1) and the portion arranged on the anterior wall B1d in the fusion promoting sheet 100.
 次に、術者は、空腸B2の吻合予定部位(空腸B2に形成される貫通孔B2aの周辺)の空腸漿膜筋層を挿通するように両端針920aを運針する。術者は、このような操作を繰り返し、癒合促進シート100、膵実質B1、および空腸B2の空腸漿膜筋層に複数の両端針920a~920eを挿通させる。このように、術者は、膵実質B1と空腸B2を縫合する複数の両端針920a~920eを利用して、癒合促進シート100を膵実質B1に固定できる。 Next, the surgeon moves the needles 920a at both ends so as to insert the serosal muscular layer of the jejunum at the planned anastomosis site of the jejunum B2 (around the through hole B2a formed in the jejunum B2). The operator repeats such an operation to insert a plurality of double-ended needles 920a to 920e into the jejunal serosal muscular layer of the fusion promoting sheet 100, the pancreatic parenchyma B1 and the jejunum B2. In this way, the operator can fix the fusion promoting sheet 100 to the pancreatic parenchyma B1 by using a plurality of both end needles 920a to 920e that suture the pancreatic parenchyma B1 and the jejunum B2.
 なお、膵実質B1、および空腸B2の空腸漿膜筋層に挿通させる両端針の本数や両端針を挿通させる位置は特に限定されない。また、術者は、複数の両端針920a~920eではなく、生分解性のステープル等を固定部材として、癒合促進シート100を膵実質B1に固定してもよい。 The number of both-end needles to be inserted into the jejunal serosal muscular layer of the pancreatic parenchyma B1 and the jejunum B2 and the position to insert the both-end needles are not particularly limited. Further, the surgeon may fix the fusion promoting sheet 100 to the pancreatic parenchyma B1 using biodegradable staples or the like as a fixing member instead of the plurality of double-ended needles 920a to 920e.
 次に、術者は、図25に示すように、術者の指を以って空腸B2を膵実質B1に対して押さえつけながら両端針920a~920eを結紮する。これによって、膵実質B1と空腸B2が癒合促進シート100を挟み込んだ状態で縫合される(図26を参照)。空腸B2は、縫合時に生じる張力により、膵実質B1の切断面B1aおよび癒合促進シート100の本体部110を包み込むように変形する。 Next, as shown in FIG. 25, the operator ligates the needles 920a to 920e at both ends while pressing the jejunum B2 against the pancreatic parenchyma B1 with the operator's finger. As a result, the pancreatic parenchyma B1 and the jejunum B2 are sutured with the fusion promoting sheet 100 sandwiched therein (see FIG. 26). The jejunum B2 is deformed by the tension generated during suturing so as to wrap around the cut surface B1a of the pancreatic parenchyma B1 and the main body 110 of the fusion promoting sheet 100.
 術者は、上記操作により、膵実質B1の切断面B1aと空腸B2の腸壁との間に、癒合促進シート100の本体部110を留置することができる。また、術者は、膵実質B1と空腸B2との間に、医療器具200をいわゆる内瘻チューブとして留置することができる。癒合促進シート100の本体部110は、膵実質B1の切断面B1aと空腸B2の腸壁とに接触しつつ、膵実質B1の切断面B1aと空腸B2の腸壁との間に留置されることにより、膵実質B1の生体組織と空腸B2の腸壁の生体組織の癒合を促進する。また、医療器具200は、術者が生体器官を吻合してから所定の期間(数週間~数か月)が経過した後に、自然に空腸B2に脱落し、体外に導出される。 By the above operation, the operator can place the main body 110 of the fusion promoting sheet 100 between the cut surface B1a of the pancreatic parenchyma B1 and the intestinal wall of the jejunum B2. In addition, the surgeon can place the medical device 200 as a so-called internal fistula tube between the pancreatic parenchyma B1 and the jejunum B2. The main body 110 of the fusion promoting sheet 100 is placed between the cut surface B1a of the pancreatic parenchyma B1 and the intestinal wall of the jejunum B2 while being in contact with the cut surface B1a of the pancreatic parenchyma B1 and the intestinal wall of the jejunum B2. This promotes the fusion of the biological tissue of the pancreatic parenchyma B1 and the biological tissue of the intestinal wall of the jejunum B2. In addition, the medical device 200 naturally falls off into the jejunum B2 after a predetermined period (several weeks to several months) has elapsed since the operator anastomosed the biological organ, and is led out of the body.
 以上のように、本実施形態に係る処置方法は、膵実質B1および空腸B2を接合する手技に適用される。また、上記の処置方法では、切断された膵実質B1の切断面B1a周辺と空腸B2の腸壁(空腸漿膜筋層)を接合する。この処置方法によれば、膵実質B1の切断面B1aと空腸B2の腸壁の間に挟み込んだ癒合促進シート100の本体部110により、膵実質B1の生体組織と空腸B2の腸壁の生体組織の癒合を促進することができ、膵実質-空腸吻合術後の縫合不全のリスクを低減させることができる。 As described above, the treatment method according to the present embodiment is applied to the procedure for joining the pancreatic parenchyma B1 and the jejunum B2. Further, in the above-mentioned treatment method, the periphery of the cut surface B1a of the cut pancreatic parenchyma B1 and the intestinal wall (jejunal serosal muscular layer) of the jejunum B2 are joined. According to this treatment method, the biological tissue of the pancreatic parenchyma B1 and the biological tissue of the intestinal wall of the jejunum B2 are formed by the main body 110 of the fusion promoting sheet 100 sandwiched between the cut surface B1a of the pancreatic parenchyma B1 and the intestinal wall of the jejunum B2. Can promote fusion and reduce the risk of suture failure after pancreatic parenchymal-jejunostomy.
 なお、本発明は上述した実施形態にのみ限定されず特許請求の範囲において種々の変更が可能である。例えば、上記では癒合促進シートと医療器具は別体であると説明したが、一体であってもよい。 The present invention is not limited to the above-described embodiment, and various modifications can be made within the scope of the claims. For example, although the fusion promotion sheet and the medical device have been described above as separate bodies, they may be integrated.
 また、上記では、固定部を本体部の軸方向Xにおける片側に配置する医療器具の実施形態について説明した。しかし、医療器具を配置する生体管腔に固定部が係止しやすい形状であれば、図27に示すように、固定部220を本体部210の軸方向Xにおける両側に配置してもよい。このように固定部220を医療器具200Aの両側に設けることによって、医療器具の生体器官に対する固定力が増加することが期待できる(図28を参照)。なお、本体部210の両側に配置されている固定部220をそれぞれ牽引するための牽引部250の各々は、互いに接続されていてもよい。これにより、術者は、本体部210の両側に配置されている固定部220を一度に操作することができる。 Further, in the above, the embodiment of the medical device in which the fixed portion is arranged on one side in the axial direction X of the main body portion has been described. However, as shown in FIG. 27, the fixing portions 220 may be arranged on both sides of the main body portion 210 in the axial direction X, as long as the fixing portions are easily locked in the living lumen in which the medical device is arranged. By providing the fixing portions 220 on both sides of the medical device 200A in this way, it can be expected that the fixing force of the medical device to the biological organ will increase (see FIG. 28). In addition, each of the traction portions 250 for traction of the fixing portions 220 arranged on both sides of the main body portion 210 may be connected to each other. As a result, the operator can operate the fixing portions 220 arranged on both sides of the main body portion 210 at once.
 また、上記では本体部の軸方向Xにおける片側に固定部が1つ設けている医療器具の実施形態について説明したが、固定部は医療器具の一端部側に複数設けられていてもよい。この場合、一の固定部と他の固定部との間隔は、医療器具が拡張状態のときに本体部の外周面より径方向に突出して延在する梁部の高さ(図4に示すt1を参照)より狭いことが好ましい。これにより、固定部の各々が消化管の内壁に反発することによって径方向内方に倒れてしまう可能性を抑制することができる。そのため、このように配置された固定部によれば、消化管に対する医療器具の固定力が手技中に低下してしまうことを抑制することができる。 Further, although the embodiment of the medical device in which one fixing portion is provided on one side in the axial direction X of the main body portion has been described above, a plurality of fixing portions may be provided on one end side of the medical device. In this case, the distance between one fixed portion and the other fixed portion is the height of the beam portion extending radially from the outer peripheral surface of the main body portion when the medical device is in the expanded state (t1 shown in FIG. 4). It is preferable that it is narrower. As a result, it is possible to suppress the possibility that each of the fixed portions repels the inner wall of the digestive tract and falls inward in the radial direction. Therefore, according to the fixing portion arranged in this way, it is possible to prevent the fixing force of the medical device from the gastrointestinal tract from being reduced during the procedure.
 また、医療器具の一端部側に複数の固定部が設けられている場合、本体部は、牽引部によって外力が与えられたときに、本体部が固定部の各々を起点として軸方向Xに直交する方向から視てW字状に折れ曲がる場合がある。このように配置された固定部によれば、医療器具の外形を拡張させることができ、消化管に対する医療器具の固定力をより確保することが期待できる。 Further, when a plurality of fixing portions are provided on one end side of the medical device, the main body portion is orthogonal to the axial direction X with each of the fixing portions as a starting point when an external force is applied by the traction portion. It may bend in a W shape when viewed from the direction in which it is used. According to the fixing portion arranged in this way, the outer shape of the medical device can be expanded, and it can be expected that the fixing force of the medical device to the digestive tract is further secured.
 また、医療器具の一端部側に複数の固定部が設けられている場合、本体部のルーメンに管状部材(以下、内部チューブと称する)がさらに設けられていてもよい。内部チューブは、牽引部によって外力が与えられたときに、本体部が固定部の各々を起点として軸方向Xに直交する方向から視てW字状に折れ曲がることを防止し、膵液が本体部のルーメンを通過しやすくすることができる。また、内部チューブは、牽引部によって外力が与えられたときに、外力が複数の梁部に均一に伝わるように固定部を補助することができる。そのため、内部チューブは、固定部を均一に拡張させて医療器具の固定力を維持することができる。 Further, when a plurality of fixing portions are provided on one end side of the medical device, a tubular member (hereinafter referred to as an internal tube) may be further provided on the lumen of the main body portion. The internal tube prevents the main body from bending in a W shape when viewed from the direction orthogonal to the axial direction X with each of the fixed parts as the starting point when an external force is applied by the traction part, and the pancreatic juice of the main body It can make it easier to pass through the lumen. Further, the internal tube can assist the fixing portion so that the external force is uniformly transmitted to the plurality of beam portions when the external force is applied by the traction portion. Therefore, the internal tube can uniformly expand the fixing portion to maintain the fixing force of the medical device.
 なお、内部チューブの外径は、本体部の内径より小さい限り、特に限定されない。また、内部チューブの構成材料は、本体部または固定部より硬い材料で構成することができる限り、特に限定されない。また、内部チューブの軸方向Xに対する長さは、特に限定されないが、内部チューブの先端側端部は、本体部の先端側に配置される一の固定部(先端側の固定部)より先端側に配置され、内部チューブの基端側端部は、一の固定部より基端側に配置される他の固定部(末端側の固定部)より基端側に配置されていることが好ましい。そのため、内部チューブは、接続部から孔部にかけて延在していることが好ましく、接続部から末端側の固定部にかけて延在していることがより好ましい。また、本体部に対する内部チューブの接続方法や接続位置は、特に限定されないが、内部チューブは接続部で本体部と接続されていてもよい。また、内部チューブが本体部と接続されていない場合、本体部の内表面や内部チューブの外表面には、シリコーンオイルなどの潤滑コーティングが施されていてもよい。この場合、本体部に対する内部チューブの潤滑性が向上し、内部チューブが本体部のルーメンをよりスムーズに動くことができる。そのため、術者が牽引部を牽引する時に必要な力を小さくすることができる。なお、本体部の内表面や内部チューブの外表面に滑り性を与える材料は、先に述べた潤滑コーティングに限定されず、摩擦係数の小さい材料の組み合わせることによって構成することができる。 The outer diameter of the inner tube is not particularly limited as long as it is smaller than the inner diameter of the main body. Further, the constituent material of the inner tube is not particularly limited as long as it can be composed of a material harder than the main body portion or the fixed portion. The length of the inner tube with respect to the axial direction X is not particularly limited, but the end portion of the inner tube on the tip end side is on the tip end side of one fixing portion (fixed portion on the tip end side) arranged on the tip end side of the main body portion. It is preferable that the base end side end portion of the inner tube is arranged on the base end side of the other fixing portion (terminal side fixing portion) arranged on the base end side of one fixed portion. Therefore, the inner tube preferably extends from the connecting portion to the hole portion, and more preferably extends from the connecting portion to the fixing portion on the terminal side. The method and position of connecting the internal tube to the main body are not particularly limited, but the internal tube may be connected to the main body at the connecting portion. When the inner tube is not connected to the main body, the inner surface of the main body and the outer surface of the inner tube may be coated with a lubricant such as silicone oil. In this case, the lubricity of the inner tube with respect to the main body is improved, and the inner tube can move the lumen of the main body more smoothly. Therefore, the force required when the operator pulls the traction portion can be reduced. The material that imparts slipperiness to the inner surface of the main body and the outer surface of the inner tube is not limited to the above-mentioned lubricating coating, and can be formed by combining materials having a small coefficient of friction.
 また、上記では、本体部を内瘻チューブとして機能するように配置する実施形態について説明した。しかし、本体部は、外瘻チューブとして機能するように配置してもよい。この場合、本体部は、膵実質、空腸及び皮膚を貫通するように、体内から体外に向けて配置される。そして、本体部は、体外に向かう端部が排液バッグに接続されることによって、膵液を体外へ排液することができる。本体部は、所定の期間が経過した後に、術者が本体部を牽引することによって体外に導出される。 Further, in the above, the embodiment in which the main body portion is arranged so as to function as an internal fistula tube has been described. However, the body may be arranged to function as an external fistula tube. In this case, the main body is arranged from the inside of the body to the outside of the body so as to penetrate the pancreatic parenchyma, the jejunum and the skin. Then, the pancreatic juice can be drained to the outside of the body by connecting the end portion of the main body toward the outside of the body to the drainage bag. The main body is pulled out of the body by the operator pulling the main body after a predetermined period of time has elapsed.
 本出願は、2020年3月30日に出願された日本国特許出願第2020-60482号に基づいており、その開示内容は、参照により全体として引用されている。 This application is based on Japanese Patent Application No. 2020-60482 filed on March 30, 2020, the disclosure of which is cited as a whole by reference.
1 医療器具セット、
100 癒合促進シート、
200 医療器具、
210 本体部(管状部材)、
220 固定部、
221 孔部、
222 梁部、
230 操作部、
240 補助部、
250 牽引部、
260 接続部、
270 孔部(挿通孔)、
280 係止部。
1 Medical equipment set,
100 fusion promotion sheet,
200 medical devices,
210 Main body (tubular member),
220 fixed part,
221 hole,
222 Beam,
230 operation unit,
240 Auxiliary part,
250 tow part,
260 connections,
270 hole (insertion hole),
280 locking part.

Claims (7)

  1.  接合対象となる一対の消化管の間に配置され、ルーメンを備える管状部材と、
     少なくとも一方の消化管に対して前記管状部材を固定可能に構成するための固定力を生じさせる固定部と、を有し、
     前記固定部は、外力によって外形を拡張可能に構成される、医療器具。
    A tubular member located between a pair of gastrointestinal tracts to be joined and having lumens,
    It has a fixing portion that generates a fixing force for forming the tubular member so that it can be fixed to at least one gastrointestinal tract.
    The fixed portion is a medical device whose outer shape can be expanded by an external force.
  2.  前記外力を前記固定部に伝えることによって前記固定部を変形させる操作部をさらに備える、請求項1に記載の医療器具。 The medical device according to claim 1, further comprising an operation unit that deforms the fixed portion by transmitting the external force to the fixed portion.
  3.  前記操作部は、牽引されることによって前記固定部に前記外力を付与し、前記固定部を軸方向に圧縮させる牽引部と、
     前記管状部材に対する前記牽引部の接続を可能にする接続部と、を備える、請求項2に記載の医療器具。
    The operating portion includes a traction portion that applies an external force to the fixed portion by being pulled and compresses the fixed portion in the axial direction.
    The medical device according to claim 2, further comprising a connection portion that enables connection of the traction portion to the tubular member.
  4.  前記操作部が前記固定部に前記外力を伝えている状態を維持する補助部をさらに備える、請求項3に記載の医療器具。 The medical device according to claim 3, further comprising an auxiliary unit for maintaining a state in which the operating unit transmits the external force to the fixed unit.
  5.  前記補助部は、前記管状部材に形成され、前記管状部材の前記軸方向の端部に形成された前記固定部より中央側に配置され、前記牽引部を前記ルーメンに挿入した状態において前記牽引部を外部に露出させる挿通孔と、
     前記牽引部および前記挿通孔の少なくとも一方に設けられ、前記牽引部の少なくとも一部を前記挿通孔に係止可能に構成される係止部と、を備える、請求項4に記載の医療器具。
    The auxiliary portion is formed on the tubular member, is arranged on the center side of the fixed portion formed at the axial end portion of the tubular member, and is the traction portion in a state where the traction portion is inserted into the lumen. With an insertion hole that exposes to the outside,
    The medical device according to claim 4, further comprising a locking portion provided on at least one of the traction portion and the insertion hole so that at least a part of the traction portion can be locked in the insertion hole.
  6.  前記固定部は、前記管状部材の前記軸方向の端部に設けられている複数の孔部と、前記孔部の各々の間にそれぞれ配置される複数の梁部とを有し、
     前記固定部は、前記牽引部によって前記軸方向に圧縮されると、前記梁部の各々を放射方向外向きに折り曲げることによって、前記外形を拡張させる、請求項3~5のいずれか1項に記載の医療器具。
    The fixing portion has a plurality of holes provided at the axial ends of the tubular member and a plurality of beam portions respectively arranged between the holes.
    According to any one of claims 3 to 5, when the fixed portion is compressed in the axial direction by the traction portion, each of the beam portions is bent outward in the radial direction to expand the outer shape. The medical device described.
  7.  請求項1~6のいずれか1項に記載の医療器具と、
     前記一対の消化管の間に配置されることにより前記一対の消化管の癒合を促進する癒合促進シートと、を有する医療器具セット。
    The medical device according to any one of claims 1 to 6 and
    A medical device set comprising a fusion promoting sheet that promotes fusion of the pair of digestive tracts by being arranged between the pair of digestive tracts.
PCT/JP2021/008959 2020-03-30 2021-03-08 Medical instrument and medical instrument set WO2021199933A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2022511715A JPWO2021199933A1 (en) 2020-03-30 2021-03-08
CN202180008266.9A CN114929299A (en) 2020-03-30 2021-03-08 Medical instrument and medical instrument set

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020-060482 2020-03-30
JP2020060482 2020-03-30

Publications (1)

Publication Number Publication Date
WO2021199933A1 true WO2021199933A1 (en) 2021-10-07

Family

ID=77927901

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2021/008959 WO2021199933A1 (en) 2020-03-30 2021-03-08 Medical instrument and medical instrument set

Country Status (3)

Country Link
JP (1) JPWO2021199933A1 (en)
CN (1) CN114929299A (en)
WO (1) WO2021199933A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005103303A (en) * 2003-09-30 2005-04-21 Ethicon Endo Surgery Inc Single lumen arrangement ring for intralumenal anastomosis
JP2019162405A (en) * 2018-03-19 2019-09-26 テルモ株式会社 Treatment method

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005103303A (en) * 2003-09-30 2005-04-21 Ethicon Endo Surgery Inc Single lumen arrangement ring for intralumenal anastomosis
JP2019162405A (en) * 2018-03-19 2019-09-26 テルモ株式会社 Treatment method

Also Published As

Publication number Publication date
JPWO2021199933A1 (en) 2021-10-07
CN114929299A (en) 2022-08-19

Similar Documents

Publication Publication Date Title
US11596408B2 (en) Magnetic anastomosis devices and methods of delivery
JP4187411B2 (en) Device for use in closing a septal defect
JP4264943B2 (en) Non-permanent biocompatible fixture
JP4673305B2 (en) Surgical graft
US20060235446A1 (en) Article, system, and method for securing medical device to tissue or organ
JP2010527744A (en) Medical instruments, systems and methods for closing perforations
JP2007502161A5 (en)
JP7361041B2 (en) Fusion promoting devices and medical devices
WO2020196857A1 (en) Fusion promotion device
WO2021199933A1 (en) Medical instrument and medical instrument set
WO2020196885A1 (en) Medical device
WO2020196856A1 (en) Medical device
US20200078009A1 (en) Delivery tools for medical implants and methods of using the same
JP2020162752A (en) Medical device
JP2021159093A (en) Medical instrument and medical instrument set
JP2021159095A (en) Medical instrument and medical instrument set
JP7410130B2 (en) Healing promotion device
WO2020196887A1 (en) Medical device
JP2020162749A (en) Fusion promotion device
JP7415214B1 (en) Cosmetic surgery mesh assembly
JP7390361B2 (en) Healing promotion device
WO2021065997A1 (en) Medical device
JP2020162781A (en) Medical device
JP2023150128A (en) Medical member and medical device
JP2022147528A (en) Fusion-accelerating device and medical appliance set

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21782422

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2022511715

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21782422

Country of ref document: EP

Kind code of ref document: A1